| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | calcium channel activity | 7.42e-09 | 129 | 91 | 9 | GO:0005262 | |
| GeneOntologyMolecularFunction | calcium ion transmembrane transporter activity | 2.94e-08 | 151 | 91 | 9 | GO:0015085 | |
| GeneOntologyMolecularFunction | cytoskeletal protein binding | CACNA1C BIN1 LIMA1 DLC1 ANK1 BRCA2 IQGAP2 TRPM7 CENPF TTLL6 ARHGEF7 SYNE1 SPTAN1 SYNE2 CAPN3 ITPRID2 DAAM1 ACE | 1.93e-06 | 1099 | 91 | 18 | GO:0008092 |
| GeneOntologyMolecularFunction | monoatomic cation channel activity | CACNA1C CATSPER1 KCNT2 TRPM3 TRPM7 TRPC4 CACHD1 RYR1 RYR2 ITPR2 | 3.68e-06 | 343 | 91 | 10 | GO:0005261 |
| GeneOntologyMolecularFunction | monoatomic ion channel activity | CACNA1C CATSPER1 KCNT2 TRPM3 TRPM7 TRPC4 CACHD1 RYR1 RYR2 ITPR2 | 4.55e-05 | 459 | 91 | 10 | GO:0005216 |
| GeneOntologyMolecularFunction | metal ion transmembrane transporter activity | CACNA1C CATSPER1 KCNT2 TRPM3 TRPM7 TRPC4 CACHD1 RYR1 RYR2 ITPR2 | 5.08e-05 | 465 | 91 | 10 | GO:0046873 |
| GeneOntologyMolecularFunction | voltage-gated calcium channel activity | 5.69e-05 | 46 | 91 | 4 | GO:0005245 | |
| GeneOntologyMolecularFunction | actin binding | BIN1 LIMA1 IQGAP2 TRPM7 SYNE1 SPTAN1 SYNE2 ITPRID2 DAAM1 ACE | 6.50e-05 | 479 | 91 | 10 | GO:0003779 |
| GeneOntologyMolecularFunction | intracellularly gated calcium channel activity | 7.11e-05 | 18 | 91 | 3 | GO:0015278 | |
| GeneOntologyMolecularFunction | ryanodine-sensitive calcium-release channel activity | 1.23e-04 | 4 | 91 | 2 | GO:0005219 | |
| GeneOntologyMolecularFunction | inorganic cation transmembrane transporter activity | CACNA1C CATSPER1 KCNT2 TRPM3 TRPM7 TRPC4 CACHD1 RYR1 RYR2 ATP6V0A2 ITPR2 | 1.30e-04 | 627 | 91 | 11 | GO:0022890 |
| GeneOntologyMolecularFunction | channel activity | CACNA1C CATSPER1 KCNT2 TRPM3 TRPM7 TRPC4 CACHD1 RYR1 RYR2 ITPR2 | 1.38e-04 | 525 | 91 | 10 | GO:0015267 |
| GeneOntologyMolecularFunction | passive transmembrane transporter activity | CACNA1C CATSPER1 KCNT2 TRPM3 TRPM7 TRPC4 CACHD1 RYR1 RYR2 ITPR2 | 1.40e-04 | 526 | 91 | 10 | GO:0022803 |
| GeneOntologyMolecularFunction | cytoskeleton-nuclear membrane anchor activity | 2.04e-04 | 5 | 91 | 2 | GO:0140444 | |
| GeneOntologyMolecularFunction | monoatomic cation transmembrane transporter activity | CACNA1C CATSPER1 KCNT2 TRPM3 TRPM7 TRPC4 CACHD1 RYR1 RYR2 ATP6V0A2 ITPR2 | 2.14e-04 | 664 | 91 | 11 | GO:0008324 |
| GeneOntologyMolecularFunction | calcium-induced calcium release activity | 3.04e-04 | 6 | 91 | 2 | GO:0048763 | |
| GeneOntologyMolecularFunction | ligand-gated calcium channel activity | 3.75e-04 | 31 | 91 | 3 | GO:0099604 | |
| GeneOntologyMolecularFunction | ligand-gated monoatomic cation channel activity | 4.52e-04 | 140 | 91 | 5 | GO:0099094 | |
| GeneOntologyMolecularFunction | intracellularly ligand-gated monoatomic ion channel activity | 4.52e-04 | 33 | 91 | 3 | GO:0005217 | |
| GeneOntologyMolecularFunction | RNA endonuclease activity, producing 3'-phosphomonoesters | 5.65e-04 | 8 | 91 | 2 | GO:0016892 | |
| GeneOntologyMolecularFunction | actin filament binding | 6.02e-04 | 227 | 91 | 6 | GO:0051015 | |
| GeneOntologyMolecularFunction | calmodulin binding | 6.45e-04 | 230 | 91 | 6 | GO:0005516 | |
| GeneOntologyMolecularFunction | inorganic molecular entity transmembrane transporter activity | CACNA1C CATSPER1 KCNT2 TRPM3 TRPM7 TRPC4 CACHD1 RYR1 RYR2 ATP6V0A2 ITPR2 | 6.54e-04 | 758 | 91 | 11 | GO:0015318 |
| GeneOntologyMolecularFunction | voltage-gated monoatomic cation channel activity | 6.57e-04 | 152 | 91 | 5 | GO:0022843 | |
| GeneOntologyMolecularFunction | gated channel activity | 8.37e-04 | 334 | 91 | 7 | GO:0022836 | |
| GeneOntologyMolecularFunction | monoatomic ion transmembrane transporter activity | CACNA1C CATSPER1 KCNT2 TRPM3 TRPM7 TRPC4 CACHD1 RYR1 RYR2 ATP6V0A2 ITPR2 | 9.47e-04 | 793 | 91 | 11 | GO:0015075 |
| GeneOntologyMolecularFunction | voltage-gated monoatomic ion channel activity | 1.47e-03 | 182 | 91 | 5 | GO:0005244 | |
| GeneOntologyMolecularFunction | voltage-gated channel activity | 1.54e-03 | 184 | 91 | 5 | GO:0022832 | |
| GeneOntologyMolecularFunction | inositol 1,4,5 trisphosphate binding | 1.80e-03 | 14 | 91 | 2 | GO:0070679 | |
| GeneOntologyMolecularFunction | ligand-gated monoatomic ion channel activity | 1.90e-03 | 193 | 91 | 5 | GO:0015276 | |
| GeneOntologyMolecularFunction | ligand-gated channel activity | 2.08e-03 | 197 | 91 | 5 | GO:0022834 | |
| GeneOntologyMolecularFunction | endonuclease activity, active with either ribo- or deoxyribonucleic acids and producing 3'-phosphomonoesters | 3.70e-03 | 20 | 91 | 2 | GO:0016894 | |
| GeneOntologyBiologicalProcess | calcium ion transmembrane transport | CACNA1C BIN1 CATSPER1 TRPM3 TRPM7 TRPC4 CAPN3 CACHD1 RYR1 RYR2 ITPR2 | 1.23e-06 | 392 | 91 | 11 | GO:0070588 |
| GeneOntologyBiologicalProcess | calcium ion transport | CACNA1C BIN1 CATSPER1 TRPM3 TRPM7 TRPC4 CAPN3 CACHD1 ACE RYR1 RYR2 ITPR2 | 2.41e-06 | 509 | 91 | 12 | GO:0006816 |
| GeneOntologyBiologicalProcess | regulation of ventricular cardiac muscle cell action potential | 1.78e-05 | 12 | 91 | 3 | GO:0098911 | |
| GeneOntologyBiologicalProcess | cell cycle checkpoint signaling | 4.96e-05 | 217 | 91 | 7 | GO:0000075 | |
| GeneOntologyBiologicalProcess | inorganic cation transmembrane transport | CACNA1C BIN1 CATSPER1 ANK1 KCNT2 TRPM3 TRPM7 TRPC4 CAPN3 CACHD1 RYR1 RYR2 ATP6V0A2 ITPR2 | 4.98e-05 | 922 | 91 | 14 | GO:0098662 |
| GeneOntologyBiologicalProcess | homologous chromosome orientation in meiotic metaphase I | 5.76e-05 | 3 | 91 | 2 | GO:0031619 | |
| GeneOntologyBiologicalProcess | mitotic spindle assembly checkpoint signaling | 7.56e-05 | 51 | 91 | 4 | GO:0007094 | |
| GeneOntologyBiologicalProcess | spindle assembly checkpoint signaling | 7.56e-05 | 51 | 91 | 4 | GO:0071173 | |
| GeneOntologyBiologicalProcess | replication fork processing | 8.16e-05 | 52 | 91 | 4 | GO:0031297 | |
| GeneOntologyBiologicalProcess | mitotic cell cycle checkpoint signaling | 8.51e-05 | 163 | 91 | 6 | GO:0007093 | |
| GeneOntologyBiologicalProcess | negative regulation of mitotic metaphase/anaphase transition | 8.80e-05 | 53 | 91 | 4 | GO:0045841 | |
| GeneOntologyBiologicalProcess | negative regulation of mitotic sister chromatid segregation | 8.80e-05 | 53 | 91 | 4 | GO:0033048 | |
| GeneOntologyBiologicalProcess | negative regulation of sister chromatid segregation | 8.80e-05 | 53 | 91 | 4 | GO:0033046 | |
| GeneOntologyBiologicalProcess | negative regulation of mitotic sister chromatid separation | 8.80e-05 | 53 | 91 | 4 | GO:2000816 | |
| GeneOntologyBiologicalProcess | mitotic spindle checkpoint signaling | 8.80e-05 | 53 | 91 | 4 | GO:0071174 | |
| GeneOntologyBiologicalProcess | negative regulation of organelle organization | 1.01e-04 | 421 | 91 | 9 | GO:0010639 | |
| GeneOntologyBiologicalProcess | negative regulation of metaphase/anaphase transition of cell cycle | 1.02e-04 | 55 | 91 | 4 | GO:1902100 | |
| GeneOntologyBiologicalProcess | negative regulation of chromosome separation | 1.02e-04 | 55 | 91 | 4 | GO:1905819 | |
| GeneOntologyBiologicalProcess | negative regulation of cellular component organization | XYLT1 KNTC1 PATL2 LIMA1 DLC1 CENPF ARHGEF7 SPTAN1 BUB1 DAB2 PFDN4 ACE KNL1 | 1.04e-04 | 864 | 91 | 13 | GO:0051129 |
| GeneOntologyBiologicalProcess | spindle checkpoint signaling | 1.17e-04 | 57 | 91 | 4 | GO:0031577 | |
| GeneOntologyBiologicalProcess | negative regulation of chromosome segregation | 1.17e-04 | 57 | 91 | 4 | GO:0051985 | |
| GeneOntologyBiologicalProcess | DNA-templated DNA replication | 1.38e-04 | 178 | 91 | 6 | GO:0006261 | |
| GeneOntologyBiologicalProcess | inorganic ion transmembrane transport | CACNA1C BIN1 CATSPER1 ANK1 KCNT2 TRPM3 TRPM7 TRPC4 CAPN3 CACHD1 RYR1 RYR2 ATP6V0A2 ITPR2 | 1.41e-04 | 1017 | 91 | 14 | GO:0098660 |
| GeneOntologyBiologicalProcess | DNA-templated DNA replication maintenance of fidelity | 1.43e-04 | 60 | 91 | 4 | GO:0045005 | |
| GeneOntologyBiologicalProcess | regulation of mitotic sister chromatid segregation | 1.43e-04 | 60 | 91 | 4 | GO:0033047 | |
| GeneOntologyBiologicalProcess | negative regulation of mitotic nuclear division | 1.84e-04 | 64 | 91 | 4 | GO:0045839 | |
| GeneOntologyBiologicalProcess | regulation of mitotic sister chromatid separation | 1.84e-04 | 64 | 91 | 4 | GO:0010965 | |
| GeneOntologyBiologicalProcess | meiotic metaphase I homologous chromosome alignment | 1.91e-04 | 5 | 91 | 2 | GO:0043060 | |
| GeneOntologyBiologicalProcess | mitotic sister chromatid separation | 2.20e-04 | 67 | 91 | 4 | GO:0051306 | |
| GeneOntologyBiologicalProcess | monoatomic cation transmembrane transport | CACNA1C BIN1 CATSPER1 KCNT2 TRPM3 TRPM7 TRPC4 CAPN3 CACHD1 RYR1 RYR2 ATP6V0A2 ITPR2 | 2.44e-04 | 942 | 91 | 13 | GO:0098655 |
| GeneOntologyBiologicalProcess | meiotic metaphase chromosome alignment | 2.85e-04 | 6 | 91 | 2 | GO:0051311 | |
| GeneOntologyBiologicalProcess | negative regulation of nuclear division | 3.06e-04 | 73 | 91 | 4 | GO:0051784 | |
| GeneOntologyBiologicalProcess | regulation of cardiac muscle cell action potential | 3.09e-04 | 30 | 91 | 3 | GO:0098901 | |
| GeneOntologyBiologicalProcess | regulation of chromosome segregation | 3.78e-04 | 139 | 91 | 5 | GO:0051983 | |
| GeneOntologyBiologicalProcess | regulation of chromosome separation | 4.14e-04 | 79 | 91 | 4 | GO:1905818 | |
| GeneOntologyBiologicalProcess | inorganic ion homeostasis | CACNA1C ANK1 TRPM7 TRPC4 CAPN3 PDZD8 RYR1 RYR2 ATP6V0A2 ITPR2 | 4.14e-04 | 622 | 91 | 10 | GO:0098771 |
| GeneOntologyBiologicalProcess | metal ion transport | CACNA1C BIN1 CATSPER1 KCNT2 TRPM3 TRPM7 TRPC4 CAPN3 CACHD1 ACE RYR1 RYR2 ITPR2 | 4.33e-04 | 1000 | 91 | 13 | GO:0030001 |
| GeneOntologyBiologicalProcess | negative regulation of cell cycle phase transition | 4.54e-04 | 311 | 91 | 7 | GO:1901988 | |
| GeneOntologyBiologicalProcess | regulation of action potential | 4.55e-04 | 81 | 91 | 4 | GO:0098900 | |
| GeneOntologyBiologicalProcess | DNA replication | 4.63e-04 | 312 | 91 | 7 | GO:0006260 | |
| GeneOntologyBiologicalProcess | release of sequestered calcium ion into cytosol | 4.73e-04 | 146 | 91 | 5 | GO:0051209 | |
| GeneOntologyBiologicalProcess | negative regulation of sequestering of calcium ion | 4.88e-04 | 147 | 91 | 5 | GO:0051283 | |
| GeneOntologyBiologicalProcess | regulation of sequestering of calcium ion | 5.19e-04 | 149 | 91 | 5 | GO:0051282 | |
| GeneOntologyBiologicalProcess | monoatomic cation transport | CACNA1C BIN1 CATSPER1 KCNT2 TRPM3 TRPM7 TRPC4 CAPN3 CACHD1 ACE RYR1 RYR2 ATP6V0A2 ITPR2 | 5.26e-04 | 1157 | 91 | 14 | GO:0006812 |
| GeneOntologyBiologicalProcess | regulation of calcium ion transport | 5.69e-04 | 323 | 91 | 7 | GO:0051924 | |
| GeneOntologyBiologicalProcess | ventricular cardiac muscle cell action potential | 5.79e-04 | 37 | 91 | 3 | GO:0086005 | |
| GeneOntologyBiologicalProcess | release of sequestered calcium ion into cytosol by sarcoplasmic reticulum | 5.79e-04 | 37 | 91 | 3 | GO:0014808 | |
| GeneOntologyBiologicalProcess | sequestering of calcium ion | 5.86e-04 | 153 | 91 | 5 | GO:0051208 | |
| GeneOntologyBiologicalProcess | chromosome separation | 6.23e-04 | 88 | 91 | 4 | GO:0051304 | |
| GeneOntologyBiologicalProcess | actin filament-based process | CACNA1C BIN1 LIMA1 DLC1 IQGAP2 TRPM7 ARHGEF7 SPTAN1 SYNE2 CAPN3 DAAM1 RYR2 | 6.58e-04 | 912 | 91 | 12 | GO:0030029 |
| GeneOntologyBiologicalProcess | release of sequestered calcium ion into cytosol by endoplasmic reticulum | 6.77e-04 | 39 | 91 | 3 | GO:1903514 | |
| GeneOntologyBiologicalProcess | regulation of cilium beat frequency involved in ciliary motility | 6.79e-04 | 9 | 91 | 2 | GO:0060296 | |
| GeneOntologyBiologicalProcess | regulation of organelle organization | KNTC1 PATL2 BIN1 LIMA1 DLC1 ANK1 IQGAP2 CENPF ARHGEF7 SYNE1 SPTAN1 SYNE2 BUB1 SMC6 KNL1 | 7.46e-04 | 1342 | 91 | 15 | GO:0033043 |
| GeneOntologyBiologicalProcess | regulation of heart rate by cardiac conduction | 7.84e-04 | 41 | 91 | 3 | GO:0086091 | |
| GeneOntologyBiologicalProcess | regulation of mitotic metaphase/anaphase transition | 8.31e-04 | 95 | 91 | 4 | GO:0030071 | |
| GeneOntologyBiologicalProcess | regulation of cardiac muscle cell contraction | 9.02e-04 | 43 | 91 | 3 | GO:0086004 | |
| GeneOntologyBiologicalProcess | hematopoietic stem cell proliferation | 9.02e-04 | 43 | 91 | 3 | GO:0071425 | |
| GeneOntologyBiologicalProcess | regulation of metaphase/anaphase transition of cell cycle | 9.33e-04 | 98 | 91 | 4 | GO:1902099 | |
| GeneOntologyBiologicalProcess | nucleus localization | 9.65e-04 | 44 | 91 | 3 | GO:0051647 | |
| GeneOntologyBiologicalProcess | sarcoplasmic reticulum calcium ion transport | 9.65e-04 | 44 | 91 | 3 | GO:0070296 | |
| GeneOntologyBiologicalProcess | metaphase/anaphase transition of mitotic cell cycle | 1.01e-03 | 100 | 91 | 4 | GO:0007091 | |
| GeneOntologyBiologicalProcess | cardiac conduction | 1.01e-03 | 100 | 91 | 4 | GO:0061337 | |
| GeneOntologyBiologicalProcess | maintenance of location in cell | 1.01e-03 | 259 | 91 | 6 | GO:0051651 | |
| GeneOntologyBiologicalProcess | negative regulation of cell cycle | 1.03e-03 | 464 | 91 | 8 | GO:0045786 | |
| GeneOntologyBiologicalProcess | cellular response to caffeine | 1.03e-03 | 11 | 91 | 2 | GO:0071313 | |
| GeneOntologyBiologicalProcess | intracellular calcium ion homeostasis | 1.06e-03 | 359 | 91 | 7 | GO:0006874 | |
| GeneOntologyBiologicalProcess | monoatomic cation homeostasis | CACNA1C ANK1 TRPM7 TRPC4 CAPN3 PDZD8 RYR1 RYR2 ATP6V0A2 ITPR2 | 1.08e-03 | 705 | 91 | 10 | GO:0055080 |
| GeneOntologyBiologicalProcess | negative regulation of cell cycle process | 1.11e-03 | 362 | 91 | 7 | GO:0010948 | |
| GeneOntologyBiologicalProcess | metaphase/anaphase transition of cell cycle | 1.12e-03 | 103 | 91 | 4 | GO:0044784 | |
| GeneOntologyBiologicalProcess | monoatomic ion transmembrane transport | CACNA1C BIN1 CATSPER1 KCNT2 TRPM3 TRPM7 TRPC4 CAPN3 CACHD1 RYR1 RYR2 ATP6V0A2 ITPR2 | 1.19e-03 | 1115 | 91 | 13 | GO:0034220 |
| GeneOntologyBiologicalProcess | monoatomic ion homeostasis | CACNA1C ANK1 TRPM7 TRPC4 CAPN3 PDZD8 RYR1 RYR2 ATP6V0A2 ITPR2 | 1.23e-03 | 717 | 91 | 10 | GO:0050801 |
| GeneOntologyBiologicalProcess | AV node cell to bundle of His cell signaling | 1.23e-03 | 12 | 91 | 2 | GO:0086027 | |
| GeneOntologyBiologicalProcess | AV node cell action potential | 1.23e-03 | 12 | 91 | 2 | GO:0086016 | |
| GeneOntologyBiologicalProcess | DNA synthesis involved in DNA repair | 1.24e-03 | 48 | 91 | 3 | GO:0000731 | |
| GeneOntologyBiologicalProcess | metaphase chromosome alignment | 1.29e-03 | 107 | 91 | 4 | GO:0051310 | |
| GeneOntologyBiologicalProcess | negative regulation of chromosome organization | 1.29e-03 | 107 | 91 | 4 | GO:2001251 | |
| GeneOntologyBiologicalProcess | regulation of sister chromatid segregation | 1.48e-03 | 111 | 91 | 4 | GO:0033045 | |
| GeneOntologyBiologicalProcess | intracellular monoatomic cation homeostasis | 1.50e-03 | 611 | 91 | 9 | GO:0030003 | |
| GeneOntologyBiologicalProcess | negative regulation of mitotic cell cycle | 1.56e-03 | 282 | 91 | 6 | GO:0045930 | |
| GeneOntologyBiologicalProcess | regulation of cell cycle checkpoint | 1.57e-03 | 52 | 91 | 3 | GO:1901976 | |
| GeneOntologyBiologicalProcess | regulation of actin filament-based movement | 1.66e-03 | 53 | 91 | 3 | GO:1903115 | |
| GeneOntologyBiologicalProcess | calcium ion homeostasis | 1.67e-03 | 389 | 91 | 7 | GO:0055074 | |
| GeneOntologyBiologicalProcess | cellular response to purine-containing compound | 1.69e-03 | 14 | 91 | 2 | GO:0071415 | |
| GeneOntologyBiologicalProcess | intracellular monoatomic ion homeostasis | 1.69e-03 | 622 | 91 | 9 | GO:0006873 | |
| GeneOntologyBiologicalProcess | positive regulation of transcription elongation by RNA polymerase II | 1.75e-03 | 54 | 91 | 3 | GO:0032968 | |
| GeneOntologyBiologicalProcess | negative regulation of supramolecular fiber organization | 1.81e-03 | 197 | 91 | 5 | GO:1902904 | |
| GeneOntologyBiologicalProcess | AV node cell to bundle of His cell communication | 1.95e-03 | 15 | 91 | 2 | GO:0086067 | |
| GeneOntologyBiologicalProcess | telomere maintenance via recombination | 1.95e-03 | 15 | 91 | 2 | GO:0000722 | |
| GeneOntologyBiologicalProcess | establishment of chromosome localization | 2.09e-03 | 122 | 91 | 4 | GO:0051303 | |
| GeneOntologyCellularComponent | Z disc | 3.43e-07 | 151 | 92 | 8 | GO:0030018 | |
| GeneOntologyCellularComponent | I band | 7.06e-07 | 166 | 92 | 8 | GO:0031674 | |
| GeneOntologyCellularComponent | calcium channel complex | 8.27e-07 | 73 | 92 | 6 | GO:0034704 | |
| GeneOntologyCellularComponent | sarcomere | 1.54e-06 | 249 | 92 | 9 | GO:0030017 | |
| GeneOntologyCellularComponent | myofibril | 3.27e-06 | 273 | 92 | 9 | GO:0030016 | |
| GeneOntologyCellularComponent | contractile muscle fiber | 5.34e-06 | 290 | 92 | 9 | GO:0043292 | |
| GeneOntologyCellularComponent | cell cortex | 3.77e-05 | 371 | 92 | 9 | GO:0005938 | |
| GeneOntologyCellularComponent | sarcoplasmic reticulum | 4.35e-05 | 88 | 92 | 5 | GO:0016529 | |
| GeneOntologyCellularComponent | sarcoplasmic reticulum membrane | 4.56e-05 | 45 | 92 | 4 | GO:0033017 | |
| GeneOntologyCellularComponent | voltage-gated calcium channel complex | 4.98e-05 | 46 | 92 | 4 | GO:0005891 | |
| GeneOntologyCellularComponent | membrane protein complex | CACNA1C SYNRG CATSPER1 ANK1 NDUFAF1 TRA SYNE1 TRPC4 SYNE2 DAB2 CACHD1 CTNND1 GABBR2 TRAV38-2DV8 TRAV38-1 RYR1 RYR2 ATP6V0A2 | 8.05e-05 | 1498 | 92 | 18 | GO:0098796 |
| GeneOntologyCellularComponent | caveola | 1.31e-04 | 111 | 92 | 5 | GO:0005901 | |
| GeneOntologyCellularComponent | sarcoplasm | 1.49e-04 | 114 | 92 | 5 | GO:0016528 | |
| GeneOntologyCellularComponent | outer kinetochore | 1.56e-04 | 24 | 92 | 3 | GO:0000940 | |
| GeneOntologyCellularComponent | sarcolemma | 1.94e-04 | 190 | 92 | 6 | GO:0042383 | |
| GeneOntologyCellularComponent | T-tubule | 4.10e-04 | 79 | 92 | 4 | GO:0030315 | |
| GeneOntologyCellularComponent | plasma membrane raft | 4.83e-04 | 147 | 92 | 5 | GO:0044853 | |
| GeneOntologyCellularComponent | cation channel complex | 6.03e-04 | 235 | 92 | 6 | GO:0034703 | |
| GeneOntologyCellularComponent | main axon | 6.45e-04 | 89 | 92 | 4 | GO:0044304 | |
| GeneOntologyCellularComponent | junctional sarcoplasmic reticulum membrane | 8.43e-04 | 10 | 92 | 2 | GO:0014701 | |
| GeneOntologyCellularComponent | microtubule organizing center attachment site | 1.03e-03 | 11 | 92 | 2 | GO:0034992 | |
| GeneOntologyCellularComponent | meiotic nuclear membrane microtubule tethering complex | 1.03e-03 | 11 | 92 | 2 | GO:0034993 | |
| GeneOntologyCellularComponent | nuclear membrane protein complex | 1.03e-03 | 11 | 92 | 2 | GO:0106083 | |
| GeneOntologyCellularComponent | nuclear membrane microtubule tethering complex | 1.03e-03 | 11 | 92 | 2 | GO:0106094 | |
| GeneOntologyCellularComponent | cell leading edge | 1.63e-03 | 500 | 92 | 8 | GO:0031252 | |
| GeneOntologyCellularComponent | supramolecular fiber | KNTC1 CACNA1C BIN1 DLC1 ANK1 IQGAP2 TTLL6 SYNE1 SPTAN1 SYNE2 CAPN3 RYR1 RYR2 | 1.92e-03 | 1179 | 92 | 13 | GO:0099512 |
| GeneOntologyCellularComponent | varicosity | 1.94e-03 | 15 | 92 | 2 | GO:0043196 | |
| GeneOntologyCellularComponent | supramolecular polymer | KNTC1 CACNA1C BIN1 DLC1 ANK1 IQGAP2 TTLL6 SYNE1 SPTAN1 SYNE2 CAPN3 RYR1 RYR2 | 2.04e-03 | 1187 | 92 | 13 | GO:0099081 |
| GeneOntologyCellularComponent | transmembrane transporter complex | 2.15e-03 | 523 | 92 | 8 | GO:1902495 | |
| GeneOntologyCellularComponent | plasma membrane protein complex | CACNA1C CATSPER1 TRA DAB2 CACHD1 CTNND1 GABBR2 TRAV38-2DV8 TRAV38-1 RYR1 | 2.36e-03 | 785 | 92 | 10 | GO:0098797 |
| GeneOntologyCellularComponent | condensed chromosome | 2.37e-03 | 307 | 92 | 6 | GO:0000793 | |
| GeneOntologyCellularComponent | cortical cytoskeleton | 2.54e-03 | 129 | 92 | 4 | GO:0030863 | |
| GeneOntologyCellularComponent | transporter complex | 2.93e-03 | 550 | 92 | 8 | GO:1990351 | |
| GeneOntologyCellularComponent | replication fork | 4.77e-03 | 77 | 92 | 3 | GO:0005657 | |
| MousePheno | abnormal prenatal growth/weight/body size | WDR91 FKBP10 BPTF TCTN3 BMPR2 DLC1 ANK1 TIAL1 BRCA2 TRPM7 ARHGEF7 PRRC2C SPTAN1 SMC6 DAB2 ZMYM2 DAAM1 MED23 ACE RYR1 RYR2 | 2.70e-06 | 1493 | 66 | 21 | MP:0004196 |
| MousePheno | lethality throughout fetal growth and development | CACNA1C TCTN3 BMPR2 BRCA2 ARHGEF7 SPTAN1 DAAM1 MED23 RYR1 RYR2 | 3.40e-05 | 435 | 66 | 10 | MP:0006208 |
| MousePheno | decreased calcium uptake by cardiac muscle | 6.57e-05 | 3 | 66 | 2 | MP:0012557 | |
| MousePheno | abnormal embryonic growth/weight/body size | WDR91 BPTF TCTN3 BMPR2 DLC1 TIAL1 BRCA2 TRPM7 ARHGEF7 PRRC2C SPTAN1 SMC6 DAB2 ZMYM2 MED23 ACE RYR2 | 7.65e-05 | 1295 | 66 | 17 | MP:0002088 |
| MousePheno | embryonic lethality during organogenesis, complete penetrance | BPTF TCTN3 BMPR2 DLC1 BRCA2 ARHGEF7 KIAA0586 BUB1 SMC6 DAB2 MED23 RYR2 | 9.22e-05 | 700 | 66 | 12 | MP:0011098 |
| MousePheno | abnormal muscle fiber morphology | 1.15e-04 | 406 | 66 | 9 | MP:0004087 | |
| MousePheno | abnormal sarcoplasmic reticulum morphology | 1.66e-04 | 23 | 66 | 3 | MP:0004088 | |
| MousePheno | abnormal embryonic tissue morphology | CACNA1C FKBP10 BPTF TCTN3 BMPR2 DLC1 BRCA2 ARHGEF7 PRRC2C SPTAN1 KIAA0586 DAB2 ARHGAP29 ZMYM2 MED23 | 1.72e-04 | 1116 | 66 | 15 | MP:0002085 |
| MousePheno | abnormal prenatal body size | WDR91 BPTF TCTN3 ANK1 TIAL1 BRCA2 TRPM7 ARHGEF7 PRRC2C SPTAN1 SMC6 DAB2 DAAM1 MED23 ACE | 1.72e-04 | 1116 | 66 | 15 | MP:0010866 |
| MousePheno | prenatal growth retardation | FKBP10 BPTF BMPR2 DLC1 BRCA2 ARHGEF7 SPTAN1 SMC6 ZMYM2 MED23 ACE RYR1 RYR2 | 1.78e-04 | 869 | 66 | 13 | MP:0010865 |
| MousePheno | embryonic lethality during organogenesis | BPTF TCTN3 BMPR2 DLC1 BRCA2 ARHGEF7 SPTAN1 KIAA0586 BUB1 SMC6 DAB2 MED23 RYR2 | 1.93e-04 | 876 | 66 | 13 | MP:0006207 |
| MousePheno | abnormal skeletal muscle fiber triad morphology | 2.18e-04 | 5 | 66 | 2 | MP:0009411 | |
| MousePheno | abnormal intracellular organelle morphology | FKBP10 BRCA2 IQGAP2 SYNE2 KIAA0586 BUB1 CDK5RAP1 CTNND1 RYR1 RYR2 | 2.24e-04 | 546 | 66 | 10 | MP:0014239 |
| MousePheno | impaired exercise endurance | 2.94e-04 | 68 | 66 | 4 | MP:0012106 | |
| MousePheno | skeletal muscle degeneration | 3.73e-04 | 30 | 66 | 3 | MP:0009415 | |
| MousePheno | abnormal chorion morphology | 4.07e-04 | 74 | 66 | 4 | MP:0002836 | |
| MousePheno | abnormal embryo size | WDR91 BPTF TCTN3 TIAL1 BRCA2 TRPM7 ARHGEF7 PRRC2C SPTAN1 SMC6 DAB2 MED23 ACE | 4.52e-04 | 956 | 66 | 13 | MP:0001697 |
| MousePheno | abnormal muscle electrophysiology | 4.52e-04 | 32 | 66 | 3 | MP:0004145 | |
| MousePheno | absent anterior visceral endoderm | 4.54e-04 | 7 | 66 | 2 | MP:0012159 | |
| MousePheno | abnormal sarcomere morphology | 4.73e-04 | 77 | 66 | 4 | MP:0004090 | |
| MousePheno | abnormal muscle fiber mitochondrial morphology | 4.96e-04 | 33 | 66 | 3 | MP:0014342 | |
| MousePheno | fatigue | 4.97e-04 | 78 | 66 | 4 | MP:0002899 | |
| MousePheno | embryonic lethality between implantation and placentation, complete penetrance | 5.86e-04 | 506 | 66 | 9 | MP:0011095 | |
| MousePheno | abnormal calcium ion homeostasis | 6.02e-04 | 404 | 66 | 8 | MP:0004231 | |
| MousePheno | increased fibroblast cell migration | 6.04e-04 | 8 | 66 | 2 | MP:0011709 | |
| MousePheno | abnormal exercise endurance | 6.89e-04 | 85 | 66 | 4 | MP:0002332 | |
| Domain | Ion_trans_dom | 7.04e-08 | 114 | 89 | 8 | IPR005821 | |
| Domain | Ion_trans | 7.04e-08 | 114 | 89 | 8 | PF00520 | |
| Domain | RIH_assoc | 2.07e-06 | 6 | 89 | 3 | PF08454 | |
| Domain | RIH_assoc-dom | 2.07e-06 | 6 | 89 | 3 | IPR013662 | |
| Domain | RIH_dom | 2.07e-06 | 6 | 89 | 3 | IPR000699 | |
| Domain | Ins145_P3_rcpt | 2.07e-06 | 6 | 89 | 3 | IPR014821 | |
| Domain | Ryanodine_recept-rel | 2.07e-06 | 6 | 89 | 3 | IPR015925 | |
| Domain | - | 2.07e-06 | 6 | 89 | 3 | 1.25.10.30 | |
| Domain | RYDR_ITPR | 2.07e-06 | 6 | 89 | 3 | PF01365 | |
| Domain | Ins145_P3_rec | 2.07e-06 | 6 | 89 | 3 | PF08709 | |
| Domain | MIR | 1.23e-05 | 10 | 89 | 3 | PS50919 | |
| Domain | MIR | 1.23e-05 | 10 | 89 | 3 | PF02815 | |
| Domain | MIR | 1.23e-05 | 10 | 89 | 3 | SM00472 | |
| Domain | MIR_motif | 1.23e-05 | 10 | 89 | 3 | IPR016093 | |
| Domain | Ryanrecept_TM4-6 | 6.72e-05 | 3 | 89 | 2 | IPR009460 | |
| Domain | RyR | 6.72e-05 | 3 | 89 | 2 | PF02026 | |
| Domain | Ryanodine_rcpt | 6.72e-05 | 3 | 89 | 2 | IPR003032 | |
| Domain | RR_TM4-6 | 6.72e-05 | 3 | 89 | 2 | PF06459 | |
| Domain | Ryan_recept | 6.72e-05 | 3 | 89 | 2 | IPR013333 | |
| Domain | EF-hand-dom_pair | 6.78e-05 | 287 | 89 | 8 | IPR011992 | |
| Domain | KASH | 1.34e-04 | 4 | 89 | 2 | PF10541 | |
| Domain | KASH | 1.34e-04 | 4 | 89 | 2 | IPR012315 | |
| Domain | TRPM_tetra | 1.34e-04 | 4 | 89 | 2 | IPR032415 | |
| Domain | KASH | 1.34e-04 | 4 | 89 | 2 | PS51049 | |
| Domain | TRPM_tetra | 1.34e-04 | 4 | 89 | 2 | PF16519 | |
| Domain | KASH | 1.34e-04 | 4 | 89 | 2 | SM01249 | |
| Domain | Spectrin | 1.73e-04 | 23 | 89 | 3 | PF00435 | |
| Domain | - | 2.49e-04 | 261 | 89 | 7 | 1.10.238.10 | |
| Domain | CH | 2.61e-04 | 65 | 89 | 4 | SM00033 | |
| Domain | CH | 3.47e-04 | 70 | 89 | 4 | PF00307 | |
| Domain | Spectrin_repeat | 3.49e-04 | 29 | 89 | 3 | IPR002017 | |
| Domain | - | 3.67e-04 | 71 | 89 | 4 | 1.10.418.10 | |
| Domain | CH | 4.08e-04 | 73 | 89 | 4 | PS50021 | |
| Domain | CH-domain | 4.52e-04 | 75 | 89 | 4 | IPR001715 | |
| Domain | Spectrin/alpha-actinin | 4.69e-04 | 32 | 89 | 3 | IPR018159 | |
| Domain | SPEC | 4.69e-04 | 32 | 89 | 3 | SM00150 | |
| Domain | EF-hand_8 | 5.62e-04 | 34 | 89 | 3 | PF13833 | |
| Domain | EF_hand_dom | 8.48e-04 | 232 | 89 | 6 | IPR002048 | |
| Domain | EH | 1.20e-03 | 11 | 89 | 2 | PS50031 | |
| Domain | EH | 1.20e-03 | 11 | 89 | 2 | SM00027 | |
| Domain | EH_dom | 1.20e-03 | 11 | 89 | 2 | IPR000261 | |
| Pathway | REACTOME_STIMULI_SENSING_CHANNELS | 1.11e-05 | 99 | 72 | 6 | MM14910 | |
| Pathway | REACTOME_STIMULI_SENSING_CHANNELS | 1.64e-05 | 106 | 72 | 6 | M27200 | |
| Pathway | KEGG_MEDICUS_REFERENCE_CA2_CAM_VGCC_RYR_SIGNALING_PATHWAY | 2.05e-05 | 11 | 72 | 3 | M47958 | |
| Pathway | REACTOME_ION_CHANNEL_TRANSPORT | 3.12e-05 | 176 | 72 | 7 | MM15718 | |
| Pathway | REACTOME_ION_CHANNEL_TRANSPORT | 4.01e-05 | 183 | 72 | 7 | M997 | |
| Pathway | KEGG_MEDICUS_VARIANT_SCRAPIE_CONFORMATION_PRPSC_TO_MGLUR5_CA2_APOPTOTIC_PATHWAY | 1.17e-04 | 19 | 72 | 3 | M47760 | |
| Pathway | REACTOME_CDC42_GTPASE_CYCLE | 1.38e-04 | 155 | 72 | 6 | M41808 | |
| Pathway | REACTOME_TRP_CHANNELS | 3.82e-04 | 28 | 72 | 3 | MM14943 | |
| Pathway | REACTOME_TRP_CHANNELS | 3.82e-04 | 28 | 72 | 3 | M27241 | |
| Pathway | KEGG_MEDICUS_REFERENCE_DYNEIN_RECRUITMENT_TO_THE_KINETOCHORE | 4.70e-04 | 30 | 72 | 3 | M47889 | |
| Pathway | KEGG_MEDICUS_REFERENCE_HOMOLOGOUS_RECOMBINATION | 6.24e-04 | 33 | 72 | 3 | M47842 | |
| Pathway | REACTOME_RHO_GTPASES_ACTIVATE_FORMINS | 7.38e-04 | 140 | 72 | 5 | M27550 | |
| Pubmed | Maternal Transient Receptor Potential Vanilloid 6 (Trpv6) Is Involved In Offspring Bone Development. | 8.00e-10 | 38 | 93 | 6 | 30786075 | |
| Pubmed | BPTF SYNRG LIMA1 ZBTB33 REPS1 PRRC2C SPTAN1 PDCD11 BOD1L1 CTNND1 MED23 MED17 | 2.77e-08 | 549 | 93 | 12 | 38280479 | |
| Pubmed | WDR91 BIN1 LIMA1 IQGAP2 CENPF ARHGEF7 PRRC2C SYNE1 SPTAN1 TRPC4 SYNE2 ZMYM2 CTNND1 GABBR2 UNC79 | 4.04e-08 | 963 | 93 | 15 | 28671696 | |
| Pubmed | 7.39e-08 | 4 | 93 | 3 | 19120137 | ||
| Pubmed | 3.68e-07 | 6 | 93 | 3 | 23463619 | ||
| Pubmed | Essential Roles of Intracellular Calcium Release Channels in Muscle, Brain, Metabolism, and Aging. | 3.68e-07 | 6 | 93 | 3 | 25966694 | |
| Pubmed | 3.68e-07 | 6 | 93 | 3 | 20519450 | ||
| Pubmed | IP3Rs are sufficient for dendritic cell Ca2+ signaling in the absence of RyR1. | 3.68e-07 | 6 | 93 | 3 | 16844763 | |
| Pubmed | 6.43e-07 | 7 | 93 | 3 | 11860456 | ||
| Pubmed | 1.03e-06 | 8 | 93 | 3 | 11784029 | ||
| Pubmed | Roles of IP3R and RyR Ca2+ channels in endoplasmic reticulum stress and beta-cell death. | 1.03e-06 | 8 | 93 | 3 | 19033399 | |
| Pubmed | Identification of proximal SUMO-dependent interactors using SUMO-ID. | 3.10e-06 | 444 | 93 | 9 | 34795231 | |
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | SYNRG LIMA1 BMPR2 DLC1 TRPM7 PRRC2C SPTAN1 SYNE2 BOD1L1 ITPRID2 HNRNPUL1 CTNND1 | 3.26e-06 | 861 | 93 | 12 | 36931259 |
| Pubmed | 3.65e-06 | 453 | 93 | 9 | 29656893 | ||
| Pubmed | 4.00e-06 | 12 | 93 | 3 | 19095005 | ||
| Pubmed | Genome-wide CRISPR screens identify novel regulators of wild-type and mutant p53 stability. | KNTC1 SYNRG BRCA2 PRRC2C BUB1 TSEN34 ZMYM2 ITPRID2 POLK KNL1 | 4.06e-06 | 588 | 93 | 10 | 38580884 |
| Pubmed | The PHLPP1 N-Terminal Extension Is a Mitotic Cdk1 Substrate and Controls an Interactome Switch. | 5.96e-06 | 256 | 93 | 7 | 33397691 | |
| Pubmed | P120 catenin represses transcriptional activity through Kaiso in endothelial cells. | 7.07e-06 | 2 | 93 | 2 | 20382170 | |
| Pubmed | 7.07e-06 | 2 | 93 | 2 | 12087177 | ||
| Pubmed | 7.07e-06 | 2 | 93 | 2 | 11792814 | ||
| Pubmed | Nesprin-1 and nesprin-2 regulate endothelial cell shape and migration. | 7.07e-06 | 2 | 93 | 2 | 24931616 | |
| Pubmed | 7.07e-06 | 2 | 93 | 2 | 17259277 | ||
| Pubmed | The SNP rs560426 Within ABCA4-ARHGAP29 Locus and the Risk of Nonsyndromic Oral Clefts. | 7.07e-06 | 2 | 93 | 2 | 31950859 | |
| Pubmed | Ryanodine receptor oligomeric interaction: identification of a putative binding region. | 7.07e-06 | 2 | 93 | 2 | 14722100 | |
| Pubmed | Structural and functional interactions within ryanodine receptor. | 7.07e-06 | 2 | 93 | 2 | 26009179 | |
| Pubmed | 7.07e-06 | 2 | 93 | 2 | 32899693 | ||
| Pubmed | Kaiso is a genome-wide repressor of transcription that is essential for amphibian development. | 7.07e-06 | 2 | 93 | 2 | 15548582 | |
| Pubmed | Mitochondrial calcium overload is a key determinant in heart failure. | 7.07e-06 | 2 | 93 | 2 | 26217001 | |
| Pubmed | 7.07e-06 | 2 | 93 | 2 | 20660191 | ||
| Pubmed | 7.07e-06 | 2 | 93 | 2 | 24040197 | ||
| Pubmed | 7.07e-06 | 2 | 93 | 2 | 15138284 | ||
| Pubmed | Ryanodine receptors in human pancreatic beta cells: localization and effects on insulin secretion. | 7.07e-06 | 2 | 93 | 2 | 15033925 | |
| Pubmed | Ryanodine receptor-ankyrin interaction regulates internal Ca2+ release in mouse T-lymphoma cells. | 7.07e-06 | 2 | 93 | 2 | 7629097 | |
| Pubmed | 7.07e-06 | 2 | 93 | 2 | 22768332 | ||
| Pubmed | 7.07e-06 | 2 | 93 | 2 | 28769046 | ||
| Pubmed | 7.07e-06 | 2 | 93 | 2 | 28158491 | ||
| Pubmed | Effect of KNL1 on the proliferation and apoptosis of colorectal cancer cells. | 7.07e-06 | 2 | 93 | 2 | 31315522 | |
| Pubmed | BIN1 localizes the L-type calcium channel to cardiac T-tubules. | 7.07e-06 | 2 | 93 | 2 | 20169111 | |
| Pubmed | Syne-1 and Syne-2 play crucial roles in myonuclear anchorage and motor neuron innervation. | 7.07e-06 | 2 | 93 | 2 | 17267447 | |
| Pubmed | Nesprins: tissue-specific expression of epsilon and other short isoforms. | 7.07e-06 | 2 | 93 | 2 | 24718612 | |
| Pubmed | 7.07e-06 | 2 | 93 | 2 | 11576544 | ||
| Pubmed | 7.07e-06 | 2 | 93 | 2 | 24586179 | ||
| Pubmed | 7.07e-06 | 2 | 93 | 2 | 19141287 | ||
| Pubmed | 7.07e-06 | 2 | 93 | 2 | 22590627 | ||
| Pubmed | Phosphorylation of ankyrin down-regulates its cooperative interaction with spectrin and protein 3. | 7.07e-06 | 2 | 93 | 2 | 2970468 | |
| Pubmed | 7.07e-06 | 2 | 93 | 2 | 30542613 | ||
| Pubmed | 7.07e-06 | 2 | 93 | 2 | 17761684 | ||
| Pubmed | 7.07e-06 | 2 | 93 | 2 | 31578382 | ||
| Pubmed | 7.07e-06 | 2 | 93 | 2 | 15280431 | ||
| Pubmed | Expression of the ryanodine receptor isoforms in immune cells. | 7.07e-06 | 2 | 93 | 2 | 11673493 | |
| Pubmed | 7.07e-06 | 2 | 93 | 2 | 15817151 | ||
| Pubmed | 7.07e-06 | 2 | 93 | 2 | 11673462 | ||
| Pubmed | 7.07e-06 | 2 | 93 | 2 | 18927079 | ||
| Pubmed | Crystal structures of wild type and disease mutant forms of the ryanodine receptor SPRY2 domain. | 7.07e-06 | 2 | 93 | 2 | 25370123 | |
| Pubmed | 7.07e-06 | 2 | 93 | 2 | 24474278 | ||
| Pubmed | Association of CACNA1C and SYNE1 in offspring of patients with psychiatric disorders. | 7.07e-06 | 2 | 93 | 2 | 27620326 | |
| Pubmed | Thermodynamics of calmodulin binding to cardiac and skeletal muscle ryanodine receptor ion channels. | 7.07e-06 | 2 | 93 | 2 | 18618700 | |
| Pubmed | The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers. | BPTF ZBTB33 TIAL1 BRCA2 PRRC2C SMC6 ZMYM2 PDCD11 BOD1L1 HNRNPUL1 RFC3 KNL1 | 9.19e-06 | 954 | 93 | 12 | 36373674 |
| Pubmed | FKBP10 NDUFAF1 TRPM7 SYNE1 SPTAN1 SYNE2 CDK5RAP1 PDCD11 PDZD8 ITPRID2 DAAM1 HNRNPUL1 CTNND1 ATP6V0A2 ITPR2 | 9.21e-06 | 1487 | 93 | 15 | 33957083 | |
| Pubmed | 1.01e-05 | 16 | 93 | 3 | 32994313 | ||
| Pubmed | Calcium handling precedes cardiac differentiation to initiate the first heartbeat. | 1.22e-05 | 17 | 93 | 3 | 27725084 | |
| Pubmed | Identifying biological pathways that underlie primordial short stature using network analysis. | BPTF LIMA1 TIAL1 CENPF SYNE1 SYNE2 PDCD11 ITPRID2 HNRNPUL1 CTNND1 RFC3 ITPR2 | 1.85e-05 | 1024 | 93 | 12 | 24711643 |
| Pubmed | 2.12e-05 | 3 | 93 | 2 | 25129075 | ||
| Pubmed | 2.12e-05 | 3 | 93 | 2 | 18403125 | ||
| Pubmed | Kaiso interacts with p120-catenin to regulate β-catenin expression at the transcriptional level. | 2.12e-05 | 3 | 93 | 2 | 24498333 | |
| Pubmed | Sequential multisite phospho-regulation of KNL1-BUB3 interfaces at mitotic kinetochores. | 2.12e-05 | 3 | 93 | 2 | 25661489 | |
| Pubmed | Nuclear import of the BTB/POZ transcriptional regulator Kaiso. | 2.12e-05 | 3 | 93 | 2 | 15564377 | |
| Pubmed | 2.12e-05 | 3 | 93 | 2 | 7876312 | ||
| Pubmed | 2.12e-05 | 3 | 93 | 2 | 24123915 | ||
| Pubmed | An NGS-based genotyping in LQTS; minor genes are no longer minor. | 2.12e-05 | 3 | 93 | 2 | 32681117 | |
| Pubmed | 2.12e-05 | 3 | 93 | 2 | 14699141 | ||
| Pubmed | 2.12e-05 | 3 | 93 | 2 | 11206130 | ||
| Pubmed | Screening for the Biomarkers Associated with Myocardial Infarction by Bioinformatics Analysis. | 2.12e-05 | 3 | 93 | 2 | 31502863 | |
| Pubmed | The inner nuclear membrane protein Sun1 mediates the anchorage of Nesprin-2 to the nuclear envelope. | 2.12e-05 | 3 | 93 | 2 | 16079285 | |
| Pubmed | 2.12e-05 | 3 | 93 | 2 | 22331848 | ||
| Pubmed | 2.12e-05 | 3 | 93 | 2 | 14646599 | ||
| Pubmed | 2.12e-05 | 3 | 93 | 2 | 23278119 | ||
| Pubmed | 2.12e-05 | 3 | 93 | 2 | 22276175 | ||
| Pubmed | 2.12e-05 | 3 | 93 | 2 | 22948152 | ||
| Pubmed | Developmental changes in expression of the three ryanodine receptor mRNAs in the mouse brain. | 2.12e-05 | 3 | 93 | 2 | 10788707 | |
| Pubmed | The catenin p120(ctn) interacts with Kaiso, a novel BTB/POZ domain zinc finger transcription factor. | 2.12e-05 | 3 | 93 | 2 | 10207085 | |
| Pubmed | 2.12e-05 | 3 | 93 | 2 | 9642272 | ||
| Pubmed | Ca(2+)-induced Ca2+ release in myocytes from dyspedic mice lacking the type-1 ryanodine receptor. | 2.12e-05 | 3 | 93 | 2 | 7621815 | |
| Pubmed | 2.12e-05 | 3 | 93 | 2 | 25713299 | ||
| Pubmed | Molecular identification of the ryanodine receptor pore-forming segment. | 2.12e-05 | 3 | 93 | 2 | 10473538 | |
| Pubmed | MPS1/Mph1 phosphorylates the kinetochore protein KNL1/Spc7 to recruit SAC components. | 2.12e-05 | 3 | 93 | 2 | 22660415 | |
| Pubmed | 2.12e-05 | 3 | 93 | 2 | 18434746 | ||
| Pubmed | 2.12e-05 | 3 | 93 | 2 | 10878022 | ||
| Pubmed | SPRY domains in ryanodine receptors (Ca(2+)-release channels). | 2.12e-05 | 3 | 93 | 2 | 9204703 | |
| Pubmed | 2.12e-05 | 3 | 93 | 2 | 21881589 | ||
| Pubmed | 2.12e-05 | 3 | 93 | 2 | 18676612 | ||
| Pubmed | Mapping the binding sites of human erythrocyte ankyrin for the anion exchanger and spectrin. | 2.12e-05 | 3 | 93 | 2 | 2141335 | |
| Pubmed | Isoform-dependent formation of heteromeric Ca2+ release channels (ryanodine receptors). | 2.12e-05 | 3 | 93 | 2 | 12213830 | |
| Pubmed | 2.12e-05 | 3 | 93 | 2 | 12408964 | ||
| Pubmed | 2.12e-05 | 3 | 93 | 2 | 9242641 | ||
| Pubmed | Ankyrin-independent membrane protein-binding sites for brain and erythrocyte spectrin. | 2.12e-05 | 3 | 93 | 2 | 2971657 | |
| Pubmed | Direct association of the reticulon protein RTN1A with the ryanodine receptor 2 in neurons. | 2.12e-05 | 3 | 93 | 2 | 23454728 | |
| Pubmed | 2.12e-05 | 3 | 93 | 2 | 17462627 | ||
| Pubmed | p120 and Kaiso regulate Helicobacter pylori-induced expression of matrix metalloproteinase-7. | 2.12e-05 | 3 | 93 | 2 | 18653469 | |
| Pubmed | 2.12e-05 | 3 | 93 | 2 | 23223241 | ||
| Interaction | PML interactions | TCTN3 SYNRG LIMA1 ZBTB33 ZFYVE9 REPS1 SYNE2 NAB1 SMC6 ZMYM2 MED23 MED17 POLK KNL1 ITPR2 | 1.52e-05 | 933 | 90 | 15 | int:PML |
| Interaction | PHLPP1 interactions | 1.80e-05 | 333 | 90 | 9 | int:PHLPP1 | |
| Interaction | CDC42 interactions | WDR91 FKBP10 LIMA1 BMPR2 TENM3 IQGAP2 TRPM7 ARHGEF7 SYNE1 SPTAN1 SYNE2 ARHGAP29 DCBLD1 PDZD8 DAAM1 CTNND1 RFC3 ITPR2 | 1.87e-05 | 1323 | 90 | 18 | int:CDC42 |
| Interaction | RHOA interactions | LIMA1 BMPR2 DLC1 ZFYVE9 TENM3 TRPM7 SPTAN1 SYNE2 DAB2 ARHGAP29 DCBLD1 PDCD11 PDZD8 DAAM1 CTNND1 ATP6V0A2 ITPR2 | 1.96e-05 | 1199 | 90 | 17 | int:RHOA |
| Interaction | NUP43 interactions | BPTF BRCA2 PRRC2C DDX60 SYNE2 ZMYM2 PDCD11 BOD1L1 ITPRID2 ZHX1 RYR2 KNL1 | 2.15e-05 | 625 | 90 | 12 | int:NUP43 |
| Interaction | RHOQ interactions | BMPR2 ZFYVE9 IQGAP2 TRPM7 ARHGEF7 SPTAN1 PDZD8 CACHD1 DAAM1 CTNND1 | 2.78e-05 | 442 | 90 | 10 | int:RHOQ |
| Interaction | PRELID2 interactions | 5.60e-05 | 17 | 90 | 3 | int:PRELID2 | |
| Cytoband | 2q14 | 2.21e-04 | 11 | 93 | 2 | 2q14 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr13q13 | 6.35e-04 | 82 | 93 | 3 | chr13q13 | |
| GeneFamily | Ryanodine receptors|Protein phosphatase 1 regulatory subunits | 3.58e-05 | 3 | 63 | 2 | 287 | |
| GeneFamily | Spectrin repeat containing nuclear envelope family | 7.14e-05 | 4 | 63 | 2 | 1252 | |
| GeneFamily | Transient receptor potential cation channels | 1.24e-04 | 28 | 63 | 3 | 249 | |
| GeneFamily | EF-hand domain containing | 9.89e-04 | 219 | 63 | 5 | 863 | |
| Coexpression | GSE27291_0H_VS_7D_STIM_GAMMADELTA_TCELL_UP | 3.09e-07 | 188 | 91 | 8 | M8452 | |
| Coexpression | HALLMARK_MITOTIC_SPINDLE | 4.75e-07 | 199 | 91 | 8 | M5893 | |
| Coexpression | HAMAI_APOPTOSIS_VIA_TRAIL_UP | KNTC1 BPTF LIMA1 IQGAP2 SYNE2 SMC6 ETAA1 DAAM1 POLK ZHX1 KNL1 ITPR2 | 2.84e-06 | 656 | 91 | 12 | M18979 |
| Coexpression | GSE13547_CTRL_VS_ANTI_IGM_STIM_BCELL_12H_UP | 4.11e-06 | 187 | 91 | 7 | M2984 | |
| Coexpression | EPPERT_PROGENITOR | 8.82e-06 | 138 | 91 | 6 | M19232 | |
| Coexpression | PUJANA_BRCA2_PCC_NETWORK | 1.76e-05 | 426 | 91 | 9 | M9516 | |
| Coexpression | KENNY_CTNNB1_TARGETS_UP | 2.77e-05 | 50 | 91 | 4 | M11067 | |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C4_CYCLING_NK_CELL | KNTC1 BRCA2 CENPF TIPIN SYNE2 BUB1 SMC6 DAB2 RFC3 KLRC2 KNL1 | 2.87e-05 | 694 | 91 | 11 | M45767 |
| Coexpression | GSE6269_HEALTHY_VS_STAPH_AUREUS_INF_PBMC_UP | 2.98e-05 | 171 | 91 | 6 | M5655 | |
| Coexpression | GSE13547_CTRL_VS_ANTI_IGM_STIM_BCELL_2H_UP | 4.35e-05 | 183 | 91 | 6 | M2993 | |
| Coexpression | GSE14415_TCONV_VS_FOXP3_KO_INDUCED_TREG_DN | 4.62e-05 | 185 | 91 | 6 | M2965 | |
| Coexpression | GSE3982_CENT_MEMORY_CD4_TCELL_VS_TH1_UP | 6.74e-05 | 198 | 91 | 6 | M5586 | |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C2_PROMONOCYTE_LIKE_CELL | 6.91e-05 | 290 | 91 | 7 | M45736 | |
| Coexpression | GSE24634_NAIVE_CD4_TCELL_VS_DAY7_IL4_CONV_TREG_DN | 7.12e-05 | 200 | 91 | 6 | M4593 | |
| Coexpression | GSE27786_LIN_NEG_VS_ERYTHROBLAST_DN | 7.12e-05 | 200 | 91 | 6 | M4793 | |
| Coexpression | GSE2770_UNTREATED_VS_IL12_TREATED_ACT_CD4_TCELL_2H_UP | 7.12e-05 | 200 | 91 | 6 | M6090 | |
| Coexpression | AIZARANI_LIVER_C20_LSECS_3 | 7.69e-05 | 295 | 91 | 7 | M39121 | |
| Coexpression | GAZDA_DIAMOND_BLACKFAN_ANEMIA_PROGENITOR_DN | 8.31e-05 | 66 | 91 | 4 | M12812 | |
| Coexpression | HOWARD_NK_CELL_INACT_MONOV_INFLUENZA_A_INDONESIA_05_2005_H5N1_AGE_18_49YO_3DY_UP | 9.34e-05 | 68 | 91 | 4 | M41108 | |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C3_CYCLING_DEFINITIVE_ERYTHROBLAST | 1.74e-04 | 450 | 91 | 8 | M45747 | |
| Coexpression | GOBERT_OLIGODENDROCYTE_DIFFERENTIATION_UP | 1.82e-04 | 578 | 91 | 9 | M2368 | |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_DN | BPTF DLC1 ZFYVE9 BRCA2 CENPF ARHGEF7 PRRC2C SYNE2 ARHGAP29 ZMYM2 DAAM1 | 1.85e-04 | 856 | 91 | 11 | M4500 |
| Coexpression | GSE14415_NATURAL_TREG_VS_FOXP3_KO_NATURAL_TREG_UP | 1.91e-04 | 152 | 91 | 5 | M2964 | |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_COMMON_DN | 2.20e-04 | 466 | 91 | 8 | M13522 | |
| Coexpression | GOBERT_OLIGODENDROCYTE_DIFFERENTIATION_UP | 2.32e-04 | 597 | 91 | 9 | MM1309 | |
| Coexpression | LAKE_ADULT_KIDNEY_C29_UNKNOWN_NOVEL_PT_CFH_POS_SUBPOPULATION_S2 | 2.32e-04 | 86 | 91 | 4 | M39248 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Maxillary Arch_top-relative-expression-ranked_2500_k-means-cluster#5 | BPTF ZBTB33 ZFYVE9 REPS1 BRCA2 CENPF ARHGEF7 SYNE2 KIAA0586 SMC6 ZMYM2 BOD1L1 HNRNPUL1 MED23 KNL1 | 5.05e-08 | 629 | 89 | 15 | Facebase_RNAseq_e10.5_Maxillary Arch_2500_K5 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_1000_k-means-cluster#2 | CATSPER1 BRCA2 CENPF KIZ SYNE2 KIAA0586 SMC6 ZMYM2 BOD1L1 KNL1 | 7.20e-07 | 311 | 89 | 10 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_1000_K2 |
| CoexpressionAtlas | facebase_RNAseq_e10.5_NeuroEpith_central_2500_K4 | XYLT1 KNTC1 BPTF CFAP54 ABCA4 KCNT2 BRCA2 TRPM7 CENPF ARHGEF7 SPTAN1 SYNE2 KIAA0586 BUB1 SMC6 ETAA1 ZMYM2 BOD1L1 HNRNPUL1 KNL1 | 7.41e-07 | 1370 | 89 | 20 | facebase_RNAseq_e10.5_NeuroEpith_central_2500_K4 |
| CoexpressionAtlas | facebase_RNAseq_e10.5_MandArch_2500_K1 | CACNA1C LIMA1 ZBTB33 BRCA2 TRPM7 CENPF TIPIN BUB1 SMC6 ETAA1 ZMYM2 BOD1L1 PFDN4 RFC3 ACE KNL1 ITPR2 | 1.34e-05 | 1241 | 89 | 17 | facebase_RNAseq_e10.5_MandArch_2500_K1 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Medial Eminence_top-relative-expression-ranked_2500_k-means-cluster#4 | BPTF ZBTB33 ZFYVE9 REPS1 KCNT2 ARHGEF7 SYNE2 KIAA0586 PDZD8 BOD1L1 HNRNPUL1 | 3.85e-05 | 595 | 89 | 11 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Medial Eminence_2500_K4 |
| CoexpressionAtlas | Fetal Liver, SC.STSL.FL, IgM- CD24- CD117+ IL7R- CD150- CD48- AA4.1+ CD43+, Fetal Liver, avg-2 | 5.56e-05 | 410 | 89 | 9 | GSM791122_500 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Maxillary Arch_top-relative-expression-ranked_1000 | WDR91 LIMA1 CATSPER1 REPS1 BRCA2 CENPF SYNE1 SYNE2 SMC6 ZMYM2 IRAK2 BOD1L1 MED17 KNL1 | 6.04e-05 | 989 | 89 | 14 | Facebase_RNAseq_e10.5_Maxillary Arch_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Maxillary Arch_top-relative-expression-ranked_1000_k-means-cluster#3 | 8.29e-05 | 432 | 89 | 9 | Facebase_RNAseq_e10.5_Maxillary Arch_1000_K3 | |
| CoexpressionAtlas | facebase_RNAseq_e10.5_MandArch_2500 | CACNA1C LIMA1 ZBTB33 BRCA2 TRPM7 CENPF TIPIN BUB1 SMC6 ETAA1 ZMYM2 BOD1L1 PFDN4 RFC3 ACE KNL1 ITPR2 | 1.11e-04 | 1468 | 89 | 17 | facebase_RNAseq_e10.5_MandArch_2500 |
| CoexpressionAtlas | FacebaseRNAseq_e9.5_Mandibular Arch_top-relative-expression-ranked_2500_k-means-cluster#2 | BPTF ZBTB33 ZFYVE9 REPS1 KIAA0586 HNRNPUL1 MED23 ZHX1 KNL1 ITPR2 | 1.25e-04 | 564 | 89 | 10 | Facebase_RNAseq_e9.5_Mandibular Arch_2500_K2 |
| CoexpressionAtlas | facebase_RNAseq_e10.5_Emin_MedNas_2500_K1 | XYLT1 CFAP54 BRCA2 IQGAP2 TRPM7 CENPF ARHGEF7 SYNE2 KIAA0586 BUB1 SMC6 ZMYM2 BOD1L1 KNL1 | 1.26e-04 | 1060 | 89 | 14 | facebase_RNAseq_e10.5_Emin_MedNas_2500_K1 |
| CoexpressionAtlas | Stromal Cells, BEC.SLN, gp38- CD31+, Lymph Node, avg-4 | 1.31e-04 | 459 | 89 | 9 | GSM777037_500 | |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Floor Plate_top-relative-expression-ranked_2500_k-means-cluster#1 | 1.54e-04 | 469 | 89 | 9 | Facebase_RNAseq_e8.5_Floor Plate_2500_K1 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_2500_k-means-cluster#5 | TCTN3 BRCA2 CENPF ARHGEF7 KIZ TIPIN SYNE2 KIAA0586 SMC6 ZMYM2 BOD1L1 KNL1 | 1.78e-04 | 831 | 89 | 12 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_2500_K5 |
| CoexpressionAtlas | facebase_RNAseq_e10.5_Emin_LatNas_2500_K3 | XYLT1 BPTF ZBTB33 KCNT2 BRCA2 TRPM7 CENPF SYNE2 KIAA0586 BUB1 SMC6 ETAA1 ZMYM2 BOD1L1 KNL1 | 2.15e-04 | 1257 | 89 | 15 | facebase_RNAseq_e10.5_Emin_LatNas_2500_K3 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Mandibular Arch_top-relative-expression-ranked_500 | 2.20e-04 | 492 | 89 | 9 | Facebase_RNAseq_e10.5_Mandibular Arch_500 | |
| CoexpressionAtlas | B cells, proB.FrA.BM, CD19- IgM- CD43+ CD24intermediate CD45R+ AA4.1+ CD, Bone marrow, avg-2 | 2.25e-04 | 388 | 89 | 8 | GSM538352_500 | |
| CoexpressionAtlas | dev gonad_e13.5_F_VascAssocMesenchStromOvary_Sma_k-means-cluster#1_top-relative-expression-ranked_500 | 2.79e-04 | 75 | 89 | 4 | gudmap_dev gonad_e13.5_F_VascAssocMesenchStromOvary_Sma_k1_500 | |
| CoexpressionAtlas | alpha beta T cells, T.8Eff.Sp.OT1.d5.VSVOva, CD8+ CD45.1+, Spleen, avg-3 | 3.26e-04 | 410 | 89 | 8 | GSM538387_500 | |
| CoexpressionAtlas | B cells, proB.CLP.FL, CD19- IgM- CD43+ CD24intermediate AA4.1+ CD45R- CD, Fetal Liver, avg-2 | 3.77e-04 | 419 | 89 | 8 | GSM538348_500 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Lateral Nasal Eminence_top-relative-expression-ranked_2500_k-means-cluster#1 | TCTN3 CATSPER1 REPS1 BRCA2 CENPF KIZ TIPIN SYNE2 KIAA0586 ZMYM2 POLK | 4.12e-04 | 780 | 89 | 11 | Facebase_RNAseq_e10.5_Lateral Nasal Eminence_2500_K1 |
| CoexpressionAtlas | DevelopingGonad_e16.5_ovary_emap-9563_top-relative-expression-ranked_1000 | NDUFAF1 TRPM7 ARHGEF7 PRRC2C SYNE2 KIAA0586 USP40 ARHGAP29 RYR1 RYR2 ITPR2 | 4.83e-04 | 795 | 89 | 11 | gudmap_developingGonad_e16.5_ovary_1000 |
| CoexpressionAtlas | dev gonad_e13.5_M_GermCell_Oct_k-means-cluster#1_top-relative-expression-ranked_1000 | 5.02e-04 | 333 | 89 | 7 | gudmap_dev gonad_e13.5_M_GermCell_Oct_k1_1000 | |
| CoexpressionAtlas | B cells, preB.FrC.BM, CD19+ IgM- CD45R+ CD43+ HSA+, Bone marrow, avg-3 | 5.14e-04 | 88 | 89 | 4 | GSM399452_100 | |
| CoexpressionAtlas | Stromal Cells, Fi.MTS15+.Th, CD45- PDGFRa+ MTS15+, Thymus, avg-3 | 5.60e-04 | 445 | 89 | 8 | GSM777043_500 | |
| CoexpressionAtlas | dev gonad_e13.5_M_GermCell_Oct_top-relative-expression-ranked_1000 | KNTC1 NDUFAF1 BRCA2 CENPF KIZ SPTAN1 KIAA0586 BUB1 CDK5RAP1 PDCD11 MED23 | 5.64e-04 | 810 | 89 | 11 | gudmap_dev gonad_e13.5_M_GermCell_Oct_1000 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ bladder_emap-6668_k-means-cluster#4_top-relative-expression-ranked_500 | 6.08e-04 | 92 | 89 | 4 | DevelopingLowerUrinaryTract_e14.5_ bladder_emap-6668_k4_500 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-6689_k-means-cluster#5_top-relative-expression-ranked_500 | 6.54e-04 | 165 | 89 | 5 | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-6689_k5_500 | |
| CoexpressionAtlas | dev gonad_e13.5_F_VascAssocMesenchStromOvary_MafB_k-means-cluster#2_top-relative-expression-ranked_500 | 6.60e-04 | 94 | 89 | 4 | gudmap_dev gonad_e13.5_F_VascAssocMesenchStromOvary_MafB_k2_500 | |
| CoexpressionAtlas | facebase_RNAseq_e10.5_MaxArch_2500_K3 | LIMA1 CFAP54 ZBTB33 BRCA2 TRPM7 CENPF SYNE2 BUB1 SMC6 ETAA1 ZMYM2 PDZD8 BOD1L1 KNL1 | 6.84e-04 | 1252 | 89 | 14 | facebase_RNAseq_e10.5_MaxArch_2500_K3 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Lateral Nasal Eminence_top-relative-expression-ranked_1000 | LIMA1 RNASE3 REPS1 ANK1 BRCA2 CENPF KIZ SYNE2 KIAA0586 ZNF790 IRAK2 DAAM1 | 8.19e-04 | 985 | 89 | 12 | Facebase_RNAseq_e10.5_Lateral Nasal Eminence_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_1000 | CATSPER1 BRCA2 CENPF ARHGEF7 KIZ SYNE2 KIAA0586 SMC6 ZMYM2 BOD1L1 DAAM1 KNL1 | 8.48e-04 | 989 | 89 | 12 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_1000 |
| ToppCell | LPS_IL1RA-Endothelial-Endothelial-Gen_Cap|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 3.57e-10 | 200 | 92 | 9 | dccec522ab0d7fff62ad6273b02aa9022dbbb8eb | |
| ToppCell | LPS_anti-TNF-Endothelial-Endothelial-Gen_Cap|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 3.57e-10 | 200 | 92 | 9 | a2b9d1cd291d17abddc3ee2e242121412c864b8b | |
| ToppCell | LPS_IL1RA-Endothelial-Endothelial|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 8.96e-09 | 200 | 92 | 8 | 72ea9882a8ed26fa1534aeb6ba0d1897dccc20c5 | |
| ToppCell | LPS_IL1RA-Endothelial|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 8.96e-09 | 200 | 92 | 8 | 5c092b2ecc081b5d04476c56333c338cd89ab984 | |
| ToppCell | LPS_only-Endothelial|LPS_only / Treatment groups by lineage, cell group, cell type | 8.96e-09 | 200 | 92 | 8 | 81e76508c9050d533853d5fd2f3097b27613d836 | |
| ToppCell | LPS_IL1RA_TNF-Endothelial-Endothelial-Activated_Gen_Cap|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 8.96e-09 | 200 | 92 | 8 | 3585484c7e24e941708bee471ca607d8ccee74e6 | |
| ToppCell | LPS_only-Endothelial-Endothelial|LPS_only / Treatment groups by lineage, cell group, cell type | 8.96e-09 | 200 | 92 | 8 | 4bb609a284d4e6066f17470a1736076aa4a1f84c | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Cycling_Myofibroblast-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 6.76e-08 | 171 | 92 | 7 | b0373ed8283ee1792b6a490bff93906546978593 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Cycling_Myofibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 6.76e-08 | 171 | 92 | 7 | b92963f9f247d2e5e2e6c51c6dbf70e527cd2f55 | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.20e-07 | 186 | 92 | 7 | f0c8de4f6ae9047b9108a47a2af8c5f42bc103b0 | |
| ToppCell | COVID-19-kidney-Proliferating_T_cell|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.44e-07 | 191 | 92 | 7 | bae388e0e9447d576e68465d73d8313ef6925ffa | |
| ToppCell | COVID-19-T_cells-Cycling_NK/T_cells|COVID-19 / group, cell type (main and fine annotations) | 1.65e-07 | 195 | 92 | 7 | 764ed100c28d9bc93ee5ecabc5291c8f184d78da | |
| ToppCell | COVID-19-lung-Proliferative_fibroblast|lung / Disease (COVID-19 only), tissue and cell type | 1.71e-07 | 196 | 92 | 7 | 2ce8a787f2731faa913d20342d73041d59468f27 | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c12-FOXP3|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.77e-07 | 197 | 92 | 7 | 7c9df6025b9d168bd6d041c6cff1e87e08b11847 | |
| ToppCell | (00)_Basal-(2)_GFP_FOXI1|(00)_Basal / shred by cell type by condition | 1.90e-07 | 199 | 92 | 7 | 19674e1eaeb51e4196d847cb62aa437c852951d3 | |
| ToppCell | COVID-19_Severe-immature_Neutrophil|COVID-19_Severe / Disease condition and Cell class | 1.90e-07 | 199 | 92 | 7 | f82fa9d651e78f9ebbe6264e00a48c54b1786a69 | |
| ToppCell | COVID-19_Severe-immature_Neutrophil-|COVID-19_Severe / Disease condition and Cell class | 1.90e-07 | 199 | 92 | 7 | 42ea0c19c455bdb0ae89b428d09c333104c670dc | |
| ToppCell | (01)_IL1RL1+-(2)_GFP_FOXI1|(01)_IL1RL1+ / shred by cell type by condition | 1.90e-07 | 199 | 92 | 7 | a2f7d0cabf35b80fe239fae34a77bf9344d5d743 | |
| ToppCell | LPS_only-Endothelial-Endothelial-Activated_Alv_Cap|LPS_only / Treatment groups by lineage, cell group, cell type | 1.96e-07 | 200 | 92 | 7 | edb64556b3fefe3144f73b6efe23b9ffd34091d2 | |
| ToppCell | LPS_IL1RA_TNF-Endothelial-Endothelial-Activated_Alv_Cap|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 1.96e-07 | 200 | 92 | 7 | 89821a264e872ed53e08e9d3609d5cc5c314503e | |
| ToppCell | Control_saline-Endothelial-Endothelial-Gen_Cap|Control_saline / Treatment groups by lineage, cell group, cell type | 1.96e-07 | 200 | 92 | 7 | 3b97920e1e6e2f09ddba2a861baa9c00c2970f4c | |
| ToppCell | droplet-Heart-nan-3m|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.78e-06 | 176 | 92 | 6 | 749b47eac5436fa34e0d243ffbc6f1897f4e431e | |
| ToppCell | PND14-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_T-Treg-Treg_prolif|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.78e-06 | 176 | 92 | 6 | 9e719e6323597ecfc758c957256872cd4ae24d4d | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling-Cycling_Proximal_Tubule_Epithelial_Cell_S-high|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.83e-06 | 177 | 92 | 6 | f925a15d2162d166a5b60edac3517c6b2d6cfbea | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling-Cycling_Proximal_Tubule_Epithelial_Cell_S-high|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.96e-06 | 179 | 92 | 6 | 88d44b04eb5c079531db663ed98ddb20b60feb9a | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell_cycling|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.02e-06 | 180 | 92 | 6 | 401df9cddcbca1eb8f0d2687bcacd98e95dc1493 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.02e-06 | 180 | 92 | 6 | f8a15c13d85c1bbbf86ce49bb6f86c368ddf22df | |
| ToppCell | COVID-19-Endothelial_cells-Capillary_endothelial_cells|COVID-19 / group, cell type (main and fine annotations) | 2.09e-06 | 181 | 92 | 6 | c5f9c92af1384d9089c65afdf41c6feb8345a3ae | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.09e-06 | 181 | 92 | 6 | 5f2d3a08577c440c944778d07aa993c6e7873f3d | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell-Parietal_Epithelial_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.09e-06 | 181 | 92 | 6 | c7c5f7d4c397b4613c772413a0a679377efffff3 | |
| ToppCell | droplet-Heart-nan-3m-Endothelial|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.44e-06 | 186 | 92 | 6 | 0ae5fbe9f210cb25092394267e1d3d6ed05627b8 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.52e-06 | 187 | 92 | 6 | 9351fa87b69a951af85b10bf91fe9b1cce8c0517 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Immune-Myeloid-Macrophage_Dendritic-Cycling_Mononuclear_Phagocyte|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.52e-06 | 187 | 92 | 6 | 73931a5ea73799095daff100b5f18853c57c74dc | |
| ToppCell | NS-critical-d_0-4-Lymphoid-NKT-proliferating|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 2.68e-06 | 189 | 92 | 6 | d6bd46abb072b13a6b72f1ca25d19f218cceb1ff | |
| ToppCell | PBMC-Severe-cDC_12|Severe / Compartment, Disease Groups and Clusters | 2.76e-06 | 190 | 92 | 6 | 84ee185939bdefb10705b621a70da27701eadcee | |
| ToppCell | COVID-19-Heart-EC_+_Pericyte|Heart / Disease (COVID-19 only), tissue and cell type | 2.76e-06 | 190 | 92 | 6 | a21653bfb7bafbc273f94fa7c13bfb48cf8fd562 | |
| ToppCell | pdx-Tumor_cells-T1|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells) | 2.76e-06 | 190 | 92 | 6 | d06ee5f89f1cec8db6897fe3b2a890a07cd3697b | |
| ToppCell | Bac-SEP-Lymphocyte-T_NK-CD8_TEM|Bac-SEP / Disease, Lineage and Cell Type | 2.85e-06 | 191 | 92 | 6 | 84e3aaed71bd35d73af475d610d1b7e71df9ce3f | |
| ToppCell | Mild-T/NK_proliferative|World / Disease group and Cell class | 2.85e-06 | 191 | 92 | 6 | 9dba5526fd5ea8065ad305feb2ee562335f887c6 | |
| ToppCell | human_hepatoblastoma-Tumor_cells-T1|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells) | 3.03e-06 | 193 | 92 | 6 | 4b9fa2a4424f8abe63fa7bee78db93dda04ab15f | |
| ToppCell | Adult-Mesenchymal-matrix_fibroblast_1_cell-D231|Adult / Lineage, Cell type, age group and donor | 3.03e-06 | 193 | 92 | 6 | ef2f456c094e6e3c6ee81e0668c953cb8d0e1c0a | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_cycling-mes_proliferating3_(7)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 3.12e-06 | 194 | 92 | 6 | f9070035553bc68106a9e0bdf4b507715a138aba | |
| ToppCell | LPS-IL1RA-Endothelial-Endothelial-Gen_Cap|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.12e-06 | 194 | 92 | 6 | 0b9cd96fa0b616da7cc90e92ff71157e9bba518f | |
| ToppCell | COVID-19_Moderate-CD8+_T_activated|World / disease group, cell group and cell class | 3.21e-06 | 195 | 92 | 6 | 070c5d3bdbd4ea54a579c01c37fb99bcf823982e | |
| ToppCell | PCW_05-06-Mesenchymal-Mesenchymal_cycling-mes_proliferating3_(7)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 3.21e-06 | 195 | 92 | 6 | 1a5e814e12fe37287dbfc58189e1958e2c76b5da | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_cycling|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 3.31e-06 | 196 | 92 | 6 | 1d2e0b328eb822db7521b5f5724d4bd17c0bad5f | |
| ToppCell | PCW_07-8.5-Mesenchymal-Mesenchymal_cycling-mes_proliferating3_(7)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 3.31e-06 | 196 | 92 | 6 | 1964c5003a0cb84539850a7cfe3bbb0e23a61d2d | |
| ToppCell | PCW_07-8.5-Mesenchymal-Mesenchymal_cycling|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 3.31e-06 | 196 | 92 | 6 | 73f951f7712e0aa3323676b9a4b7944d21d347c4 | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_cycling-mes_proliferating3_(7)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 3.40e-06 | 197 | 92 | 6 | 84ed777cdba569200a3ef1654d8a12f17fcfb7f1 | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_cycling|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 3.40e-06 | 197 | 92 | 6 | 8b616cde333bdbc0c591035ad9e4949155866245 | |
| ToppCell | COVID-19_Moderate-CD8+_T_activated|COVID-19_Moderate / disease group, cell group and cell class | 3.40e-06 | 197 | 92 | 6 | 4711ecb157e907758a5021248ae8b043d17672c6 | |
| ToppCell | COVID-19-Fibroblasts|COVID-19 / group, cell type (main and fine annotations) | 3.40e-06 | 197 | 92 | 6 | fb847f2277609c31fffcdf49517243ce0684facf | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_convalescent_d42-56-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell|Severe-critical_convalescent_d42-56 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 3.40e-06 | 197 | 92 | 6 | 35004d4728d33f15cc3be99a073b1ea965365c32 | |
| ToppCell | Sepsis-URO-Lymphocyte-T/NK-CD4+_CTL|URO / Disease, condition lineage and cell class | 3.51e-06 | 198 | 92 | 6 | c53405a8d082fbd10131a6ec88b69fdd835f2925 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.51e-06 | 198 | 92 | 6 | 8ab40fae14fe02e39bc8c8da187a5cd60c787643 | |
| ToppCell | medial-2-Hematologic-Proliferating_Macrophage|2 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 3.51e-06 | 198 | 92 | 6 | 64a2bcf5a9ba66a4fe08fbde33f1886c136cde8f | |
| ToppCell | medial-Hematologic-Proliferating_Macrophage-2|medial / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 3.51e-06 | 198 | 92 | 6 | fcc14ac3eb5088b9d6cd6af5a34dee5b81c0ece8 | |
| ToppCell | medial-Hematologic-Proliferating_Macrophage|medial / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 3.51e-06 | 198 | 92 | 6 | da6963184c32761c896a9b91a5321ad84b583736 | |
| ToppCell | PBMC-Severe-Lymphocyte-T/NK-Other_T-T/NK_proliferative|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 3.61e-06 | 199 | 92 | 6 | e98ff036d04fc78dffef156bdc0d644532274067 | |
| ToppCell | VE-cycling|VE / Condition, Cell_class and T cell subcluster | 3.61e-06 | 199 | 92 | 6 | 47c47ebc318a0b98841ca2656837bbd068899559 | |
| ToppCell | PBMC-Severe-Lymphocyte-T/NK-Other_T|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 3.61e-06 | 199 | 92 | 6 | 305a9ade5bbe8e981e7c641c9a5e0c9f8ef60470 | |
| ToppCell | (02)_MMP9/10+-(2)_GFP_FOXI1|(02)_MMP9/10+ / shred by cell type by condition | 3.61e-06 | 199 | 92 | 6 | 18a7f9ced4364f45b184bd529f32ef02c27779d3 | |
| ToppCell | PBMC-Severe-Lymphocyte-T/NK-Other_T-T/NK_proliferative-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 3.61e-06 | 199 | 92 | 6 | 7feedb0bf84a3361c8ab5b6674ff64e8ff140c23 | |
| ToppCell | PBMC-Mild-Lymphocyte-T/NK-Other_T|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09) | 3.61e-06 | 199 | 92 | 6 | 101f78fe6dd1bf9e2e4dd5ad8a970312b3540927 | |
| ToppCell | PBMC-Severe-Lymphocyte-T/NK-Other_T-T/NK_proliferative|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 3.61e-06 | 199 | 92 | 6 | 123fbf2122aa221d8cbf3aef9361ba0982c07695 | |
| ToppCell | PBMC-Mild-Lymphocyte-T/NK-Other_T|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 3.61e-06 | 199 | 92 | 6 | e0fcec796afe75e42467ca86355b9fc5aa9ae0a1 | |
| ToppCell | Sepsis-Leuk-UTI-Lymphocyte-T/NK-gd_T|Leuk-UTI / Disease, condition lineage and cell class | 3.61e-06 | 199 | 92 | 6 | b2c1b9ee764e1246bfa3ecf666ca76ae4ac6c362 | |
| ToppCell | COVID-19_Severe-Lymphoid_T/NK-T/NK_proliferative|COVID-19_Severe / Disease group, lineage and cell class | 3.61e-06 | 199 | 92 | 6 | ddae7fe7633661f15d3c79f5187415ffbfecce67 | |
| ToppCell | (03)_KRT6B+-(2)_GFP_FOXI1|(03)_KRT6B+ / shred by cell type by condition | 3.61e-06 | 199 | 92 | 6 | c425e7975f492ed5cfcca022248adb627e1d27d4 | |
| ToppCell | PBMC-Severe-Lymphocyte-T/NK-Other_T|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 3.61e-06 | 199 | 92 | 6 | fba48342066aab41a8bcb20db40a6df0158e1cbe | |
| ToppCell | VE-cycling-|VE / Condition, Cell_class and T cell subcluster | 3.61e-06 | 199 | 92 | 6 | c0a67149a19b65b3069dbc5261d81f658e6e39a2 | |
| ToppCell | PBMC-Severe-Lymphocyte-T/NK-Other_T-T/NK_proliferative-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 3.61e-06 | 199 | 92 | 6 | 6b1304417cf9c44ca70d2bfc2b5acc1a206f25b6 | |
| ToppCell | LPS_IL1RA-Mesenchymal_fibroblastic-Fibroblasts-Activated_MatrixFB|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 3.61e-06 | 199 | 92 | 6 | 8b86c69aaf60feff53aa782559cfece7342a23de | |
| ToppCell | LPS_anti-TNF-Endothelial-Endothelial-FOXM1|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 3.61e-06 | 199 | 92 | 6 | 98575fcce726589e93fbb4df1aab03e57cb56076 | |
| ToppCell | LPS_IL1RA-Endothelial-Endothelial-FOXM1|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 3.61e-06 | 199 | 92 | 6 | be2276c9a1994579ba1d2998b49bf549c1324d44 | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-10w-Stem_cells-Neuroepithelial_cell|10w / Sample Type, Dataset, Time_group, and Cell type. | 3.71e-06 | 200 | 92 | 6 | 8f8b8c225cdc79baf16fe04be89bdb65e404a055 | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW13-Stem_cells|GW13 / Sample Type, Dataset, Time_group, and Cell type. | 3.71e-06 | 200 | 92 | 6 | d933978b55fefe52cad599b36f6b47a0c7f71f96 | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-10w-Stem_cells|10w / Sample Type, Dataset, Time_group, and Cell type. | 3.71e-06 | 200 | 92 | 6 | a1f48eca9efb4f3ec3c9ace20f8c9257dd72c4ed | |
| ToppCell | Tracheal-NucSeq-Stromal-Chondrocytic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.71e-06 | 200 | 92 | 6 | b5a54b9baf79aea01f76a161f0a39bbe87eb4945 | |
| ToppCell | mild-CD8+_Tem|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 3.71e-06 | 200 | 92 | 6 | d8aec4904c9420b8f9d7508658ba1e36c66cdfcc | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-2m-Stem_cells-Neuroepithelial_cell|2m / Sample Type, Dataset, Time_group, and Cell type. | 3.71e-06 | 200 | 92 | 6 | 0d9b8d51a7630e70e60c76c763ff82df4c559152 | |
| ToppCell | severe-T/NK_proliferative|severe / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 3.71e-06 | 200 | 92 | 6 | 9d6e7e2d6cfa8c96bbb5c187815df96ecaa5475c | |
| ToppCell | LPS_only-Endothelial-Endothelial-Gen_Cap|LPS_only / Treatment groups by lineage, cell group, cell type | 3.71e-06 | 200 | 92 | 6 | eb94a5111ef0e903ee5be9f7efe571b4e6d5fce1 | |
| ToppCell | Tracheal-NucSeq-Stromal-Chondrocytic-Chondrocyte|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.71e-06 | 200 | 92 | 6 | f5bd0b30e478dac09f68c46b0781f5f2e7e3c693 | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-2m-Stem_cells|2m / Sample Type, Dataset, Time_group, and Cell type. | 3.71e-06 | 200 | 92 | 6 | 0675f580ccef705875854247bbfd4ee2bcf126a1 | |
| ToppCell | Sepsis-Bac-SEP-Lymphocyte-T/NK-CD8+_Tem|Bac-SEP / Disease, condition lineage and cell class | 3.71e-06 | 200 | 92 | 6 | 86e572b4fb01a429c1ad4b492214a128c0a430e3 | |
| ToppCell | Control_saline-Endothelial-Endothelial-Alv_Gen_Intermediate|Control_saline / Treatment groups by lineage, cell group, cell type | 3.71e-06 | 200 | 92 | 6 | 041a34080120c9f613373c20dcc366292f558040 | |
| ToppCell | LPS_only-Endothelial-Endothelial-Alv_Gen_Intermediate|LPS_only / Treatment groups by lineage, cell group, cell type | 3.71e-06 | 200 | 92 | 6 | b1fadb2b5e37e0f51e079d8409c2647eef68dc3b | |
| ToppCell | Control_saline-Endothelial-Endothelial|Control_saline / Treatment groups by lineage, cell group, cell type | 3.71e-06 | 200 | 92 | 6 | e77eba6172cabf85b8028638ed35299f2f079cd8 | |
| ToppCell | LPS_IL1RA-Endothelial-Endothelial-Activated_Alv_Cap|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 3.71e-06 | 200 | 92 | 6 | 79e51afb57ca38aacebd0298e5e727b55c0cfff9 | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW13-Stem_cells-Neuroepithelial_cell|GW13 / Sample Type, Dataset, Time_group, and Cell type. | 3.71e-06 | 200 | 92 | 6 | 3d932765c31aef1f80a118d51e8e66c50a758dbb | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW26-Stem_cells-Neuroepithelial_cell|GW26 / Sample Type, Dataset, Time_group, and Cell type. | 3.71e-06 | 200 | 92 | 6 | 203b9a5de4430713da01b3331e69381db449a3a0 | |
| ToppCell | LPS_anti-TNF-Endothelial-Endothelial-Activated_Gen_Cap|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 3.71e-06 | 200 | 92 | 6 | f15fffefe372005c33e31845982e2d2714ac26af | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW26-Stem_cells|GW26 / Sample Type, Dataset, Time_group, and Cell type. | 3.71e-06 | 200 | 92 | 6 | a854e19703dc920e48304541e2b06ed013292f3e | |
| ToppCell | LPS_IL1RA_TNF-Endothelial-Endothelial-Gen_Cap|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 3.71e-06 | 200 | 92 | 6 | b2d4e6f3e8e4da62e6b02758ab2ed8f505269f9a | |
| ToppCell | Control_saline-Endothelial-Endothelial-Activated_Alv_Cap|Control_saline / Treatment groups by lineage, cell group, cell type | 3.71e-06 | 200 | 92 | 6 | be55cef682ba87250dad97689332c8820b3a7420 | |
| ToppCell | Control_saline-Endothelial|Control_saline / Treatment groups by lineage, cell group, cell type | 3.71e-06 | 200 | 92 | 6 | 3372c488a39fe812fa94e4f0564594186fea3db5 | |
| ToppCell | Sepsis-Leuk-UTI-Lymphocyte-T/NK-CD8+_Tem|Leuk-UTI / Disease, condition lineage and cell class | 3.71e-06 | 200 | 92 | 6 | aa8104dcb2ba5756a23c25a580bef2360ff25b13 | |
| ToppCell | LPS-antiTNF-Endothelial-Endothelial-FOXM1|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.24e-05 | 163 | 92 | 5 | 5285318c52aa31c9b22dc2ffff078e32e408604d | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.24e-05 | 163 | 92 | 5 | 3f434015c0cbefb31eeda133c34f75384c5f7e22 | |
| Computational | Neighborhood of DFFA | 7.83e-05 | 129 | 60 | 6 | GCM_DFFA | |
| Drug | Clozapine [5786-21-0]; Down 200; 12.2uM; PC3; HT_HG-U133A | 8.64e-08 | 199 | 89 | 9 | 4670_DN | |
| Drug | lercanidipine | 1.71e-07 | 63 | 89 | 6 | CID000065866 | |
| Drug | Cinildipine | 2.66e-06 | 56 | 89 | 5 | CID000002752 | |
| Drug | nilvadipine | 3.76e-06 | 60 | 89 | 5 | CID000004494 | |
| Drug | strontium | 6.99e-06 | 68 | 89 | 5 | CID000104798 | |
| Drug | AC1L2AC7 | 7.52e-06 | 69 | 89 | 5 | CID000068733 | |
| Drug | CNS 1145 | 8.18e-06 | 33 | 89 | 4 | CID000190902 | |
| Drug | IHC-64 | 8.18e-06 | 33 | 89 | 4 | CID000162753 | |
| Drug | ethosuximide | 1.06e-05 | 74 | 89 | 5 | CID000003291 | |
| Drug | Piribedil hydrochloride [78213-63-5]; Up 200; 12uM; HL60; HT_HG-U133A | 1.19e-05 | 196 | 89 | 7 | 2951_UP | |
| Drug | Air Pollutants | LIMA1 BMPR2 KCNT2 IQGAP2 CENPF TTLL6 ARHGEF7 KIZ SYNE2 DAB2 PFDN4 ITPRID2 CTNND1 ITPR2 | 1.23e-05 | 917 | 89 | 14 | ctd:D000393 |
| Drug | nisoldipine | 1.37e-05 | 78 | 89 | 5 | CID000004499 | |
| Drug | N-cyclopentyl-N-cyclobutylformamide | 1.46e-05 | 79 | 89 | 5 | CID005287890 | |
| Drug | lanthanum | 1.57e-05 | 136 | 89 | 6 | CID000023926 | |
| Drug | AC1L1DXE | 2.26e-05 | 299 | 89 | 8 | CID000002548 | |
| Drug | FPL 64176 | 2.54e-05 | 15 | 89 | 3 | CID000003423 | |
| Drug | manidipine | 3.58e-05 | 95 | 89 | 5 | CID000004008 | |
| Drug | nitrendipine | 4.16e-05 | 98 | 89 | 5 | CID000004507 | |
| Drug | cis-diammineplatinum(II | 4.52e-05 | 3 | 89 | 2 | CID000159790 | |
| Drug | 2-hydroxyheptanoic acid | 4.52e-05 | 3 | 89 | 2 | CID002750949 | |
| Drug | 8N3-cADPR | 4.52e-05 | 3 | 89 | 2 | CID000127713 | |
| Drug | aminodantrolene | 4.52e-05 | 3 | 89 | 2 | CID009570289 | |
| Drug | 2-hydroxycarbazole | 4.52e-05 | 3 | 89 | 2 | CID000093551 | |
| Drug | Ryanodyl 3-(pyridine-3-carboxylate | 4.52e-05 | 3 | 89 | 2 | CID005748312 | |
| Drug | isradipine | 4.58e-05 | 100 | 89 | 5 | CID000003784 | |
| Drug | torcetrapib | 5.86e-05 | 342 | 89 | 8 | ctd:C483909 | |
| Drug | Baclofen | 6.27e-05 | 20 | 89 | 3 | ctd:D001418 | |
| Drug | irinotecan HCl; Down 200; 100uM; MCF7; HT_HG-U133A | 8.30e-05 | 183 | 89 | 6 | 7498_DN | |
| Drug | HPED | 9.02e-05 | 4 | 89 | 2 | CID000125856 | |
| Drug | PCB74 | 9.02e-05 | 4 | 89 | 2 | CID000036218 | |
| Drug | 148504-47-6 | 9.02e-05 | 4 | 89 | 2 | CID006444275 | |
| Drug | SC 38249 | 9.02e-05 | 4 | 89 | 2 | CID000134834 | |
| Drug | AC1L1U7A | 9.02e-05 | 4 | 89 | 2 | CID000035682 | |
| Drug | IAA-94 | 9.60e-05 | 61 | 89 | 4 | CID000003667 | |
| Drug | YM-09730-5 | 9.66e-05 | 23 | 89 | 3 | CID000002296 | |
| Drug | NSC759576 | 1.05e-04 | 191 | 89 | 6 | CID000003075 | |
| Drug | Salbutamol [18559-94-9]; Down 200; 16.8uM; PC3; HT_HG-U133A | 1.05e-04 | 191 | 89 | 6 | 7376_DN | |
| Drug | clozapine; Down 200; 10uM; HL60; HT_HG-U133A | 1.08e-04 | 192 | 89 | 6 | 6188_DN | |
| Drug | dihydropyridine | 1.11e-04 | 193 | 89 | 6 | CID000104822 | |
| Drug | Clofazimine [2030-63-9]; Down 200; 8.4uM; PC3; HT_HG-U133A | 1.14e-04 | 194 | 89 | 6 | 4682_DN | |
| Drug | pioglitazone HCl; Up 200; 10uM; MCF7; HT_HG-U133A | 1.14e-04 | 194 | 89 | 6 | 7523_UP | |
| Drug | mibefradil | 1.16e-04 | 64 | 89 | 4 | CID000060662 | |
| Drug | F0447-0125; Down 200; 10uM; MCF7; HT_HG-U133A | 1.18e-04 | 195 | 89 | 6 | 6424_DN | |
| Drug | Tacrine hydrochloride hydrate [1684-40-8]; Down 200; 15.8uM; PC3; HT_HG-U133A | 1.18e-04 | 195 | 89 | 6 | 6698_DN | |
| Drug | BAS 012416453; Up 200; 38uM; MCF7; HT_HG-U133A | 1.24e-04 | 197 | 89 | 6 | 6908_UP | |
| Drug | Neomycin sulfate [1405-10-3]; Down 200; 4.2uM; PC3; HT_HG-U133A | 1.24e-04 | 197 | 89 | 6 | 5867_DN | |
| Drug | Spaglumic acid [4910-46-7]; Up 200; 13.2uM; HL60; HT_HG-U133A | 1.28e-04 | 198 | 89 | 6 | 2962_UP | |
| Drug | 5286656; Down 200; 50uM; MCF7; HT_HG-U133A_EA | 1.28e-04 | 198 | 89 | 6 | 889_DN | |
| Drug | Theobromine [83-67-0]; Down 200; 22.2uM; HL60; HT_HG-U133A | 1.28e-04 | 198 | 89 | 6 | 2995_DN | |
| Drug | Glafenine hydrochloride [65513-72-6]; Up 200; 9.8uM; HL60; HT_HG-U133A | 1.28e-04 | 198 | 89 | 6 | 2387_UP | |
| Drug | Carteolol hydrochloride [51781-21-6]; Up 200; 12.2uM; HL60; HT_HG-U133A | 1.28e-04 | 198 | 89 | 6 | 1340_UP | |
| Drug | Ceftazidime pentahydrate [78439-06-2]; Down 200; 6.2uM; MCF7; HT_HG-U133A | 1.32e-04 | 199 | 89 | 6 | 5473_DN | |
| Drug | Gibberellic acid [77-06-5]; Down 200; 11.6uM; MCF7; HT_HG-U133A | 1.32e-04 | 199 | 89 | 6 | 7330_DN | |
| Drug | gadolinium | 1.32e-04 | 199 | 89 | 6 | CID000023982 | |
| Drug | tetraethylenepentamine pentahydrochloride; Up 200; 100uM; MCF7; HG-U133A | 1.32e-04 | 199 | 89 | 6 | 406_UP | |
| Drug | N-phenylanthranilic acid; Down 200; 10uM; MCF7; HG-U133A | 1.35e-04 | 200 | 89 | 6 | 317_DN | |
| Drug | gallopamil | 1.39e-04 | 67 | 89 | 4 | CID000001234 | |
| Drug | 2-aminoethyl diphenylborinate | 1.42e-04 | 127 | 89 | 5 | CID000001598 | |
| Drug | A 68930 | 1.50e-04 | 5 | 89 | 2 | ctd:C065380 | |
| Drug | Demecolcine | LIMA1 REPS1 BRCA2 CENPF ARHGEF7 DDX60 SYNE2 NAB1 SMC6 IRAK2 DAAM1 MED17 | 1.55e-04 | 878 | 89 | 12 | ctd:D003703 |
| Drug | CAS 298-57-7 | 1.93e-04 | 73 | 89 | 4 | CID000002761 | |
| Drug | 2,4-xylidinothiazoline | 2.17e-04 | 30 | 89 | 3 | CID000099296 | |
| Drug | chloro-m-cresol | 2.24e-04 | 6 | 89 | 2 | CID000012008 | |
| Drug | MBED | 2.24e-04 | 6 | 89 | 2 | CID000129958 | |
| Drug | AC1O528X | 2.24e-04 | 6 | 89 | 2 | CID006475857 | |
| Drug | NSC114784 | 2.24e-04 | 6 | 89 | 2 | CID000419425 | |
| Disease | Malignant neoplasm of breast | BMPR2 ABCA4 ANK1 KCNT2 BRCA2 CENPF SYNE1 SPTAN1 TRPC4 SYNE2 SMC6 ARHGAP29 BOD1L1 | 1.75e-05 | 1074 | 88 | 13 | C0006142 |
| Disease | congenital myopathy 1A (implicated_via_orthology) | 2.63e-05 | 3 | 88 | 2 | DOID:3529 (implicated_via_orthology) | |
| Disease | malignant hyperthermia (implicated_via_orthology) | 2.63e-05 | 3 | 88 | 2 | DOID:8545 (implicated_via_orthology) | |
| Disease | Myopathy, Centronuclear, Autosomal Recessive | 5.26e-05 | 4 | 88 | 2 | C0410204 | |
| Disease | Autosomal dominant Emery-Dreifuss muscular dystrophy | 5.26e-05 | 4 | 88 | 2 | cv:CN293514 | |
| Disease | Autosomal Recessive Emery-Dreifuss Muscular Dystrophy | 8.74e-05 | 5 | 88 | 2 | C1450051 | |
| Disease | Autosomal Dominant Emery-Dreifuss Muscular Dystrophy (disorder) | 8.74e-05 | 5 | 88 | 2 | C0410190 | |
| Disease | pulmonary hypertension (biomarker_via_orthology) | 9.82e-05 | 80 | 88 | 4 | DOID:6432 (biomarker_via_orthology) | |
| Disease | Emery-Dreifuss muscular dystrophy | 1.31e-04 | 6 | 88 | 2 | cv:C0410189 | |
| Disease | Muscular Dystrophy, Emery-Dreifuss | 1.31e-04 | 6 | 88 | 2 | C0410189 | |
| Disease | primary pulmonary hypertension (is_implicated_in) | 1.31e-04 | 6 | 88 | 2 | DOID:14557 (is_implicated_in) | |
| Disease | X-Linked Emery-Dreifuss Muscular Dystrophy | 1.83e-04 | 7 | 88 | 2 | C0751337 | |
| Disease | MASA syndrome (implicated_via_orthology) | 1.83e-04 | 7 | 88 | 2 | DOID:0060246 (implicated_via_orthology) | |
| Disease | bipolar disorder, schizophrenia | 2.70e-04 | 42 | 88 | 3 | MONDO_0004985, MONDO_0005090 | |
| Disease | Mental deterioration | 3.12e-04 | 9 | 88 | 2 | C0234985 | |
| Disease | Mild cognitive disorder | 3.12e-04 | 9 | 88 | 2 | C1270972 | |
| Disease | triglyceride measurement, intermediate density lipoprotein measurement | 3.47e-04 | 111 | 88 | 4 | EFO_0004530, EFO_0008595 | |
| Disease | response to tenofovir, creatinine clearance measurement | 3.59e-04 | 112 | 88 | 4 | EFO_0007934, EFO_0009279 | |
| Disease | aspartate aminotransferase measurement | WDR91 BIN1 ABCA4 TIAL1 IQGAP2 TRPM3 TRPM7 DAB2 ARHGAP29 KLRC2 | 3.61e-04 | 904 | 88 | 10 | EFO_0004736 |
| Disease | BRCA2 mutation carier statu | 3.90e-04 | 10 | 88 | 2 | EFO_0011022 | |
| Disease | Emery-Dreifuss muscular dystrophy (implicated_via_orthology) | 5.69e-04 | 12 | 88 | 2 | DOID:11726 (implicated_via_orthology) | |
| Disease | Autosomal Dominant Myotubular Myopathy | 6.71e-04 | 13 | 88 | 2 | C3661489 | |
| Disease | Centronuclear myopathy | 6.71e-04 | 13 | 88 | 2 | C0175709 | |
| Disease | X-linked centronuclear myopathy | 6.71e-04 | 13 | 88 | 2 | C0410203 | |
| Disease | Myopathy, Centronuclear, 1 | 6.71e-04 | 13 | 88 | 2 | C4551952 | |
| Disease | Congenital Structural Myopathy | 6.71e-04 | 13 | 88 | 2 | C0752282 | |
| Disease | Myopathy, Centronuclear, Autosomal Dominant | 7.82e-04 | 14 | 88 | 2 | C1834558 | |
| Disease | Tubular Aggregate Myopathy | 7.82e-04 | 14 | 88 | 2 | C0410207 | |
| Disease | Impaired cognition | 7.82e-04 | 14 | 88 | 2 | C0338656 | |
| Disease | anemia (is_implicated_in) | 7.82e-04 | 14 | 88 | 2 | DOID:2355 (is_implicated_in) | |
| Disease | Autosomal Recessive Centronuclear Myopathy | 9.00e-04 | 15 | 88 | 2 | C3645536 | |
| Disease | myocardial infarction (implicated_via_orthology) | 1.02e-03 | 66 | 88 | 3 | DOID:5844 (implicated_via_orthology) | |
| Disease | primary autosomal recessive microcephaly (is_implicated_in) | 1.03e-03 | 16 | 88 | 2 | DOID:0070296 (is_implicated_in) | |
| Disease | muscular dystrophy (is_implicated_in) | 1.16e-03 | 17 | 88 | 2 | DOID:9884 (is_implicated_in) | |
| Disease | sphingomyelin 14:0 measurement | 1.16e-03 | 17 | 88 | 2 | EFO_0010390 | |
| Disease | unipolar depression, bipolar disorder | 1.24e-03 | 156 | 88 | 4 | EFO_0003761, MONDO_0004985 | |
| Disease | Congenital Fiber Type Disproportion | 1.30e-03 | 18 | 88 | 2 | C0546264 | |
| Disease | Colorectal Neoplasms | 1.46e-03 | 277 | 88 | 5 | C0009404 | |
| Disease | non-small cell lung carcinoma | 1.48e-03 | 75 | 88 | 3 | EFO_0003060 | |
| Disease | triglyceride measurement, low density lipoprotein cholesterol measurement | 1.56e-03 | 166 | 88 | 4 | EFO_0004530, EFO_0004611 | |
| Disease | Intellectual Disability | 2.23e-03 | 447 | 88 | 6 | C3714756 | |
| Disease | Cardiac Arrhythmia | 2.52e-03 | 25 | 88 | 2 | C0003811 | |
| Disease | Colorectal cancer | 2.94e-03 | 27 | 88 | 2 | cv:C0346629 | |
| Disease | COLORECTAL CANCER | 2.94e-03 | 27 | 88 | 2 | 114500 | |
| Disease | Neoplasm of the large intestine | 2.94e-03 | 27 | 88 | 2 | cv:C0009404 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| LVQAVSQNFNFAKDV | 41 | Q6P461 | |
| QQFNTNFDENKVDVT | 156 | Q96N23 | |
| QSVNFVNDGQKNSTR | 496 | Q902F8 | |
| NEDAFEAQFQKNVRS | 496 | O43683 | |
| VASVEQEQQKFRSQA | 746 | Q8NEC5 | |
| LDQVFVNFAKQQTES | 2241 | P78363 | |
| GTQARKFDVNQLQNT | 701 | P12821 | |
| GQEEQVQEAKNTFTQ | 1781 | P16157 | |
| FQLIRSTNNNTKFQA | 321 | Q5VU97 | |
| DNSNNQLVVRAKFNF | 181 | Q14155 | |
| QLVVRAKFNFQQTNE | 186 | Q14155 | |
| TVTFQQNKNFHQTFA | 2101 | Q12830 | |
| VQDSQTFSTNFQVDN | 1286 | P20742 | |
| RDEQGSKVNDFFQQT | 2186 | Q14571 | |
| QFDQISNRTGKQEAQ | 346 | P98082 | |
| KTNVDSVFVNFQNDR | 171 | Q9UMX2 | |
| NQDINTTQNIAEVFK | 26 | Q8N387 | |
| VDNTFAEEFTTQNQK | 711 | Q9UHB6 | |
| ADVVQATDDFNQNRK | 201 | O43187 | |
| QQENDSIFKQNVTDG | 646 | Q86T24 | |
| FQDSVQTLFQQARAK | 341 | Q13506 | |
| VNQVAATVQNRFTKN | 821 | Q8IY21 | |
| TFEDQQKINKFARNT | 16 | Q9NQP4 | |
| FREFVNNNIKSNNVS | 671 | Q9HCI6 | |
| LTENKHSFQDTQFQN | 836 | Q8NEN9 | |
| NQNTFLRTTFANVVN | 66 | P12724 | |
| AFFKQNNVPQESRFN | 741 | Q9ULK4 | |
| DNQIFKQDQSNVQIA | 521 | Q8NG31 | |
| TNAFVQKANDENRRT | 121 | P50748 | |
| VTENQENKLQRDFNS | 171 | Q9NVC6 | |
| SAFKNQDQQRKSNVS | 561 | Q6UVM3 | |
| TLQDNTNQTENRFQK | 571 | Q2M2Z5 | |
| NFNQGTENEQSKETQ | 386 | P28290 | |
| DVIQEQNKRNYDFTQ | 206 | Q9NY74 | |
| FSEQQSNQVEKLFQT | 331 | C9JE40 | |
| NFTEVNEENKNDLFQ | 116 | Q52LW3 | |
| NEENKNDLFQEVFSS | 121 | Q52LW3 | |
| VFEVSKTQDNRNNNS | 1131 | Q8NFC6 | |
| FDQFLQAVSEAKQEN | 976 | Q9Y4D1 | |
| FQNQDRNQDGKITVD | 551 | Q96AY3 | |
| NDTTEINRNNNFQTF | 1436 | Q13936 | |
| QFNKNNSNQAVAVTF | 2456 | P51587 | |
| QVKESQVNFQEGQLN | 91 | P49454 | |
| VNIKEDTDFFQRTNQ | 221 | Q9Y375 | |
| VFSFANRQNFINEKN | 231 | Q13873 | |
| TTNQLFTRFSDNNQA | 521 | O15033 | |
| QNRRFQFTQNQKKED | 756 | O75899 | |
| IVNNEEKVFQGNSNF | 361 | Q8N8Z6 | |
| DEQFEQCVQNFNKQL | 41 | O00499 | |
| QESEEQQQFRNIFKQ | 646 | P20807 | |
| FKREEQNFVVQNEIN | 3451 | P21817 | |
| NFKREEQNFVVQNEI | 3411 | Q92736 | |
| KSDFQVNLNNASRSQ | 846 | O60716 | |
| AQSQQLETNSQRDFK | 116 | P40938 | |
| RQNQFYDTQVIKQEN | 106 | Q9BUJ2 | |
| SQFEVFAASNVNDEQ | 631 | Q96D71 | |
| QEQITKANEEFQAFL | 2486 | Q8NF91 | |
| TERPQFSRQKDFQQQ | 4371 | Q8WXH0 | |
| QKQFAEEQQKRFEQQ | 116 | Q9UMZ2 | |
| FLEQNNFSPNTRTQK | 96 | P26717 | |
| DDLQTNQFKNVTFDI | 1496 | Q13576 | |
| EVLQSTQRFFSEQQQ | 2816 | Q9Y520 | |
| TQRFFSEQQQSKQIG | 2821 | Q9Y520 | |
| TFNNVVEQNFKNRES | 786 | Q96QB1 | |
| FRQKENDTQIFNDSA | 316 | Q8N1H7 | |
| QNVNSFRDNSEVQFN | 316 | Q96SZ6 | |
| KAFQQSVEQDNLFDI | 21 | Q14690 | |
| SQNLAKQQRNEVSFV | 326 | Q99611 | |
| ENVDNSNFAPRTQKQ | 161 | Q86Y38 | |
| QNSVTFQEVAVDFSQ | 11 | Q13360 | |
| FKRQQEESFQEQSAL | 86 | Q9BSV6 | |
| QQNATENRFSVNFQK | 76 | P0DTU3 | |
| VFNNTFFEVKSISNQ | 1136 | Q9HCF6 | |
| EANKQQNFNTGIKDF | 1656 | Q13813 | |
| EAVNKQSFQTSQPFQ | 586 | Q9UBT6 | |
| VKRNNQTIFEQTIND | 136 | Q9UKY1 | |
| RVKAFQNQENSVNQE | 416 | Q96SB8 | |
| QQTENDTFENGKVNS | 341 | Q9P273 | |
| FQDNNSLFQNTVASR | 461 | Q8N841 | |
| AVFNTQKRENAEENN | 231 | Q06730 | |
| ETNQGQEKNSSNFIE | 126 | Q9UBW7 | |
| QFQTLQDNQEECFKQ | 126 | Q6PG37 | |
| QQNATENRFSVNFQK | 76 | A0JD32 | |
| IQQAFEKVNQRASAT | 91 | O15482 | |
| QKVNATNFQALAAEF | 176 | Q6NUS6 | |
| QTNRNDKAQEFFAKQ | 101 | A4D1P6 | |
| NNTKQLRFEDVVNQS | 186 | Q01085 | |
| QAESDFQRNDQQIFK | 416 | Q9NVE5 | |
| QQQRAAQKLTFAFNQ | 1676 | Q96QT4 | |
| QSFKNVQQQLDATSR | 281 | Q9BVW5 | |
| DNENRQTDQFSFSIN | 186 | O95405 | |
| RSKQNAAEQNANQIF | 851 | Q9UBN4 | |
| SFAKQNQESAVSQQA | 1296 | Q9BVV6 | |
| QRQQQLQFSDQSFQS | 101 | Q9Y3M9 | |
| NQNVSSFQRKFVGEV | 41 | Q9Y487 | |
| QQNATENRFSVNFQK | 76 | A0A0B4J264 | |
| VATNLQNQNEFSFTA | 2491 | Q9P2D8 |